Project
Illumina Body Map 2, young vs old
Navigation
Downloads
Results for SP4_PML
Z-value: 0.68
Motif logo
Transcription factors associated with SP4_PML
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SP4
|
ENSG00000105866.9 | Sp4 transcription factor |
|
PML
|
ENSG00000140464.15 | PML nuclear body scaffold |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| PML | hg19_v2_chr15_+_74287035_74287117 | -0.24 | 1.8e-01 | Click! |
| SP4 | hg19_v2_chr7_+_21467642_21467671 | -0.04 | 8.2e-01 | Click! |
Activity profile of SP4_PML motif
Sorted Z-values of SP4_PML motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr20_-_62130474 | 14.67 |
ENST00000217182.3
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
| chr22_-_38851205 | 10.71 |
ENST00000303592.3
|
KCNJ4
|
potassium inwardly-rectifying channel, subfamily J, member 4 |
| chr4_+_2061119 | 9.21 |
ENST00000423729.2
|
NAT8L
|
N-acetyltransferase 8-like (GCN5-related, putative) |
| chr2_-_241759622 | 8.71 |
ENST00000320389.7
ENST00000498729.2 |
KIF1A
|
kinesin family member 1A |
| chr7_-_44365020 | 8.13 |
ENST00000395747.2
ENST00000347193.4 ENST00000346990.4 ENST00000258682.6 ENST00000353625.4 ENST00000421607.1 ENST00000424197.1 ENST00000502837.2 ENST00000350811.3 ENST00000395749.2 |
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta |
| chr17_+_42836521 | 7.74 |
ENST00000535346.1
|
ADAM11
|
ADAM metallopeptidase domain 11 |
| chr2_-_230579185 | 7.52 |
ENST00000341772.4
|
DNER
|
delta/notch-like EGF repeat containing |
| chr11_-_17410869 | 7.51 |
ENST00000528731.1
|
KCNJ11
|
potassium inwardly-rectifying channel, subfamily J, member 11 |
| chr5_-_693500 | 7.39 |
ENST00000360578.5
|
TPPP
|
tubulin polymerization promoting protein |
| chr11_-_17410629 | 7.31 |
ENST00000526912.1
|
KCNJ11
|
potassium inwardly-rectifying channel, subfamily J, member 11 |
| chr11_-_12030681 | 7.27 |
ENST00000529338.1
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
| chr6_+_17393839 | 7.19 |
ENST00000489374.1
ENST00000378990.2 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
| chr1_+_236849754 | 6.98 |
ENST00000542672.1
ENST00000366578.4 |
ACTN2
|
actinin, alpha 2 |
| chr4_-_819901 | 6.96 |
ENST00000304062.6
|
CPLX1
|
complexin 1 |
| chr6_+_17393888 | 6.96 |
ENST00000493172.1
ENST00000465994.1 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
| chr6_+_163835669 | 6.94 |
ENST00000453779.2
ENST00000275262.7 ENST00000392127.2 ENST00000361752.3 |
QKI
|
QKI, KH domain containing, RNA binding |
| chr4_-_819880 | 6.93 |
ENST00000505203.1
|
CPLX1
|
complexin 1 |
| chr7_-_139477500 | 6.84 |
ENST00000406875.3
ENST00000428878.2 |
HIPK2
|
homeodomain interacting protein kinase 2 |
| chr19_-_2721336 | 6.65 |
ENST00000588128.1
|
DIRAS1
|
DIRAS family, GTP-binding RAS-like 1 |
| chr7_-_143059780 | 6.63 |
ENST00000409578.1
ENST00000409346.1 |
FAM131B
|
family with sequence similarity 131, member B |
| chr7_-_51384451 | 6.63 |
ENST00000441453.1
ENST00000265136.7 ENST00000395542.2 ENST00000395540.2 |
COBL
|
cordon-bleu WH2 repeat protein |
| chr7_-_44365216 | 6.37 |
ENST00000358707.3
ENST00000457475.1 ENST00000440254.2 |
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta |
| chr11_+_67183141 | 6.30 |
ENST00000531040.1
ENST00000307823.3 ENST00000423745.2 |
CARNS1
|
carnosine synthase 1 |
| chr19_-_2721412 | 6.07 |
ENST00000323469.4
|
DIRAS1
|
DIRAS family, GTP-binding RAS-like 1 |
| chr13_+_113548643 | 6.04 |
ENST00000375608.3
|
MCF2L
|
MCF.2 cell line derived transforming sequence-like |
| chr8_-_133493200 | 6.00 |
ENST00000388996.4
|
KCNQ3
|
potassium voltage-gated channel, KQT-like subfamily, member 3 |
| chr12_-_54982420 | 5.98 |
ENST00000257905.8
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
| chr5_-_16617162 | 5.93 |
ENST00000306320.9
|
FAM134B
|
family with sequence similarity 134, member B |
| chr5_-_45696253 | 5.91 |
ENST00000303230.4
|
HCN1
|
hyperpolarization activated cyclic nucleotide-gated potassium channel 1 |
| chr17_+_42836329 | 5.85 |
ENST00000200557.6
|
ADAM11
|
ADAM metallopeptidase domain 11 |
| chr19_-_19006890 | 5.81 |
ENST00000247005.6
|
GDF1
|
growth differentiation factor 1 |
| chr8_-_41754231 | 5.78 |
ENST00000265709.8
|
ANK1
|
ankyrin 1, erythrocytic |
| chr16_+_25703274 | 5.74 |
ENST00000331351.5
|
HS3ST4
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 4 |
| chr22_+_51039098 | 5.66 |
ENST00000399912.1
ENST00000329492.3 ENST00000442429.2 ENST00000341339.4 |
MAPK8IP2
|
mitogen-activated protein kinase 8 interacting protein 2 |
| chr11_-_12030746 | 5.57 |
ENST00000533813.1
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
| chr16_+_330581 | 5.57 |
ENST00000219409.3
|
ARHGDIG
|
Rho GDP dissociation inhibitor (GDI) gamma |
| chr19_+_589893 | 5.47 |
ENST00000251287.2
|
HCN2
|
hyperpolarization activated cyclic nucleotide-gated potassium channel 2 |
| chr3_-_183543301 | 5.47 |
ENST00000318631.3
ENST00000431348.1 |
MAP6D1
|
MAP6 domain containing 1 |
| chr7_-_143059845 | 5.39 |
ENST00000443739.2
|
FAM131B
|
family with sequence similarity 131, member B |
| chr3_-_183979251 | 5.37 |
ENST00000296238.3
|
CAMK2N2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
| chr4_-_6565315 | 5.36 |
ENST00000506140.1
|
PPP2R2C
|
protein phosphatase 2, regulatory subunit B, gamma |
| chr18_+_32073839 | 5.33 |
ENST00000590412.1
|
DTNA
|
dystrobrevin, alpha |
| chr18_-_74844727 | 5.26 |
ENST00000355994.2
ENST00000579129.1 |
MBP
|
myelin basic protein |
| chr6_+_118228657 | 5.25 |
ENST00000360388.4
|
SLC35F1
|
solute carrier family 35, member F1 |
| chr11_-_12030629 | 5.17 |
ENST00000396505.2
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
| chr19_+_35521699 | 5.11 |
ENST00000415950.3
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
| chr19_-_18717627 | 5.09 |
ENST00000392386.3
|
CRLF1
|
cytokine receptor-like factor 1 |
| chr15_-_30261066 | 5.07 |
ENST00000558447.1
|
TJP1
|
tight junction protein 1 |
| chr11_+_67183557 | 5.07 |
ENST00000445895.2
|
CARNS1
|
carnosine synthase 1 |
| chr19_-_19006920 | 5.03 |
ENST00000429504.2
ENST00000427170.2 |
CERS1
|
ceramide synthase 1 |
| chr7_-_38671098 | 4.85 |
ENST00000356264.2
|
AMPH
|
amphiphysin |
| chr22_+_42372970 | 4.85 |
ENST00000291236.11
|
SEPT3
|
septin 3 |
| chr5_+_7396141 | 4.80 |
ENST00000338316.4
|
ADCY2
|
adenylate cyclase 2 (brain) |
| chr10_-_21463116 | 4.79 |
ENST00000417816.2
|
NEBL
|
nebulette |
| chr19_-_55658281 | 4.77 |
ENST00000585321.2
ENST00000587465.2 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr1_+_1950763 | 4.72 |
ENST00000378585.4
|
GABRD
|
gamma-aminobutyric acid (GABA) A receptor, delta |
| chr8_+_21906658 | 4.71 |
ENST00000523300.1
|
DMTN
|
dematin actin binding protein |
| chr16_+_6069586 | 4.70 |
ENST00000547372.1
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chr7_-_38670957 | 4.68 |
ENST00000325590.5
ENST00000428293.2 |
AMPH
|
amphiphysin |
| chr1_-_33336414 | 4.65 |
ENST00000373471.3
ENST00000609187.1 |
FNDC5
|
fibronectin type III domain containing 5 |
| chr13_-_110438914 | 4.63 |
ENST00000375856.3
|
IRS2
|
insulin receptor substrate 2 |
| chr3_-_24536453 | 4.62 |
ENST00000453729.2
ENST00000413780.1 |
THRB
|
thyroid hormone receptor, beta |
| chr20_+_57467204 | 4.60 |
ENST00000603546.1
|
GNAS
|
GNAS complex locus |
| chr7_+_30174668 | 4.56 |
ENST00000415604.1
|
C7orf41
|
maturin, neural progenitor differentiation regulator homolog (Xenopus) |
| chr19_+_1446214 | 4.55 |
ENST00000587869.1
|
APC2
|
adenomatosis polyposis coli 2 |
| chr19_-_42498369 | 4.55 |
ENST00000302102.5
ENST00000545399.1 |
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
| chr6_-_166721871 | 4.54 |
ENST00000322583.3
|
PRR18
|
proline rich 18 |
| chr6_+_150464155 | 4.53 |
ENST00000361131.4
|
PPP1R14C
|
protein phosphatase 1, regulatory (inhibitor) subunit 14C |
| chrX_+_152953505 | 4.53 |
ENST00000253122.5
|
SLC6A8
|
solute carrier family 6 (neurotransmitter transporter), member 8 |
| chr19_+_35521616 | 4.52 |
ENST00000595652.1
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
| chr9_-_139922726 | 4.52 |
ENST00000265662.5
ENST00000371605.3 |
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2 |
| chr11_+_1411129 | 4.49 |
ENST00000308219.9
ENST00000528841.1 ENST00000531197.1 ENST00000308230.5 |
BRSK2
|
BR serine/threonine kinase 2 |
| chr16_+_330448 | 4.45 |
ENST00000447871.1
|
ARHGDIG
|
Rho GDP dissociation inhibitor (GDI) gamma |
| chr22_+_42372764 | 4.44 |
ENST00000396426.3
ENST00000406029.1 |
SEPT3
|
septin 3 |
| chr8_-_140715294 | 4.44 |
ENST00000303015.1
ENST00000520439.1 |
KCNK9
|
potassium channel, subfamily K, member 9 |
| chr8_+_21906433 | 4.42 |
ENST00000522148.1
|
DMTN
|
dematin actin binding protein |
| chr12_+_51984657 | 4.41 |
ENST00000550891.1
|
SCN8A
|
sodium channel, voltage gated, type VIII, alpha subunit |
| chr12_-_124018252 | 4.37 |
ENST00000376874.4
|
RILPL1
|
Rab interacting lysosomal protein-like 1 |
| chr7_-_4998802 | 4.37 |
ENST00000406755.1
ENST00000404774.3 ENST00000401401.3 |
MMD2
|
monocyte to macrophage differentiation-associated 2 |
| chr19_-_51222707 | 4.36 |
ENST00000391814.1
|
SHANK1
|
SH3 and multiple ankyrin repeat domains 1 |
| chr22_-_44258360 | 4.36 |
ENST00000330884.4
ENST00000249130.5 |
SULT4A1
|
sulfotransferase family 4A, member 1 |
| chr7_-_158380371 | 4.34 |
ENST00000389418.4
ENST00000389416.4 |
PTPRN2
|
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
| chr19_-_42498231 | 4.32 |
ENST00000602133.1
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
| chr3_+_50712672 | 4.32 |
ENST00000266037.9
|
DOCK3
|
dedicator of cytokinesis 3 |
| chr16_+_58497567 | 4.30 |
ENST00000258187.5
|
NDRG4
|
NDRG family member 4 |
| chr17_-_74236382 | 4.27 |
ENST00000592271.1
ENST00000319945.6 ENST00000269391.6 |
RNF157
|
ring finger protein 157 |
| chr14_+_33408449 | 4.26 |
ENST00000346562.2
ENST00000341321.4 ENST00000548645.1 ENST00000356141.4 ENST00000357798.5 |
NPAS3
|
neuronal PAS domain protein 3 |
| chr9_+_95947198 | 4.25 |
ENST00000448039.1
ENST00000297954.4 ENST00000395477.2 ENST00000395475.2 ENST00000349097.3 ENST00000427277.2 ENST00000356055.3 ENST00000432730.1 |
WNK2
|
WNK lysine deficient protein kinase 2 |
| chr13_-_102068706 | 4.25 |
ENST00000251127.6
|
NALCN
|
sodium leak channel, non-selective |
| chr11_-_35440796 | 4.24 |
ENST00000278379.3
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
| chr7_-_99869799 | 4.23 |
ENST00000436886.2
|
GATS
|
GATS, stromal antigen 3 opposite strand |
| chr11_-_12030905 | 4.20 |
ENST00000326932.4
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
| chr1_-_32229523 | 4.18 |
ENST00000398547.1
ENST00000373655.2 ENST00000373658.3 ENST00000257070.4 |
BAI2
|
brain-specific angiogenesis inhibitor 2 |
| chr9_+_137979506 | 4.18 |
ENST00000539529.1
ENST00000392991.4 ENST00000371793.3 |
OLFM1
|
olfactomedin 1 |
| chr3_-_10749696 | 4.16 |
ENST00000397077.1
|
ATP2B2
|
ATPase, Ca++ transporting, plasma membrane 2 |
| chr5_+_6448736 | 4.15 |
ENST00000399816.3
|
UBE2QL1
|
ubiquitin-conjugating enzyme E2Q family-like 1 |
| chr5_-_11904100 | 4.15 |
ENST00000359640.2
|
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
| chr3_-_196695692 | 4.15 |
ENST00000412723.1
|
PIGZ
|
phosphatidylinositol glycan anchor biosynthesis, class Z |
| chr16_+_6069072 | 4.14 |
ENST00000547605.1
ENST00000550418.1 ENST00000553186.1 |
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chr2_+_26395939 | 4.12 |
ENST00000401533.2
|
GAREML
|
GRB2 associated, regulator of MAPK1-like |
| chr18_-_70535177 | 4.12 |
ENST00000327305.6
|
NETO1
|
neuropilin (NRP) and tolloid (TLL)-like 1 |
| chr5_+_137774706 | 4.10 |
ENST00000378339.2
ENST00000254901.5 ENST00000506158.1 |
REEP2
|
receptor accessory protein 2 |
| chr1_+_6845384 | 4.08 |
ENST00000303635.7
|
CAMTA1
|
calmodulin binding transcription activator 1 |
| chr19_-_49944806 | 4.05 |
ENST00000221485.3
|
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7 |
| chr16_-_755726 | 4.03 |
ENST00000324361.5
|
FBXL16
|
F-box and leucine-rich repeat protein 16 |
| chr18_+_48086440 | 4.02 |
ENST00000400384.2
ENST00000540640.1 ENST00000592595.1 |
MAPK4
|
mitogen-activated protein kinase 4 |
| chr19_-_6502590 | 4.02 |
ENST00000264071.2
|
TUBB4A
|
tubulin, beta 4A class IVa |
| chr7_+_31092109 | 4.00 |
ENST00000409363.1
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I |
| chr14_+_67999999 | 4.00 |
ENST00000329153.5
|
PLEKHH1
|
pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 |
| chr9_+_140772226 | 3.98 |
ENST00000277551.2
ENST00000371372.1 ENST00000277549.5 ENST00000371363.1 ENST00000371357.1 ENST00000371355.4 |
CACNA1B
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
| chr17_-_79139817 | 3.97 |
ENST00000326724.4
|
AATK
|
apoptosis-associated tyrosine kinase |
| chr12_+_113012831 | 3.96 |
ENST00000547686.1
ENST00000543106.2 ENST00000551593.1 ENST00000546426.1 ENST00000551748.1 |
RPH3A
|
rabphilin 3A homolog (mouse) |
| chr9_+_138628365 | 3.95 |
ENST00000491806.2
ENST00000488444.2 ENST00000490355.2 ENST00000263604.3 |
KCNT1
|
potassium channel, subfamily T, member 1 |
| chr11_-_46940074 | 3.95 |
ENST00000378623.1
ENST00000534404.1 |
LRP4
|
low density lipoprotein receptor-related protein 4 |
| chr16_+_6069664 | 3.95 |
ENST00000422070.4
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
| chr7_-_108097144 | 3.93 |
ENST00000418239.1
|
NRCAM
|
neuronal cell adhesion molecule |
| chr19_-_6502304 | 3.93 |
ENST00000540257.1
ENST00000594276.1 ENST00000594075.1 ENST00000600216.1 ENST00000596926.1 |
TUBB4A
|
tubulin, beta 4A class IVa |
| chr5_-_11904152 | 3.92 |
ENST00000304623.8
ENST00000458100.2 |
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
| chr4_-_8160416 | 3.92 |
ENST00000505872.1
ENST00000447017.2 ENST00000341937.5 ENST00000361581.5 |
ABLIM2
|
actin binding LIM protein family, member 2 |
| chr17_-_80656528 | 3.91 |
ENST00000538809.2
ENST00000269347.6 ENST00000571995.1 |
RAB40B
|
RAB40B, member RAS oncogene family |
| chr13_+_96743093 | 3.91 |
ENST00000376705.2
|
HS6ST3
|
heparan sulfate 6-O-sulfotransferase 3 |
| chr22_+_42372931 | 3.91 |
ENST00000328414.8
ENST00000396425.3 |
SEPT3
|
septin 3 |
| chr22_+_43808014 | 3.90 |
ENST00000334209.5
ENST00000443721.1 ENST00000414469.2 ENST00000439548.1 |
MPPED1
|
metallophosphoesterase domain containing 1 |
| chr17_-_42992856 | 3.88 |
ENST00000588316.1
ENST00000435360.2 ENST00000586793.1 ENST00000588735.1 ENST00000588037.1 ENST00000592320.1 ENST00000253408.5 |
GFAP
|
glial fibrillary acidic protein |
| chr16_+_58498194 | 3.88 |
ENST00000561779.1
ENST00000565430.1 ENST00000567063.1 ENST00000566041.1 |
NDRG4
|
NDRG family member 4 |
| chr4_-_8160510 | 3.87 |
ENST00000407564.3
ENST00000361737.5 ENST00000296372.8 ENST00000545242.1 ENST00000546334.1 ENST00000318888.4 ENST00000428004.2 |
ABLIM2
|
actin binding LIM protein family, member 2 |
| chr2_-_175869936 | 3.84 |
ENST00000409900.3
|
CHN1
|
chimerin 1 |
| chr16_-_325910 | 3.82 |
ENST00000359740.5
ENST00000316163.5 ENST00000431291.2 ENST00000397770.3 ENST00000397768.3 |
RGS11
|
regulator of G-protein signaling 11 |
| chr13_-_27334879 | 3.81 |
ENST00000405846.3
|
GPR12
|
G protein-coupled receptor 12 |
| chr1_-_16400086 | 3.79 |
ENST00000375662.4
|
FAM131C
|
family with sequence similarity 131, member C |
| chr7_-_137531606 | 3.79 |
ENST00000288490.5
|
DGKI
|
diacylglycerol kinase, iota |
| chr10_+_134000404 | 3.76 |
ENST00000338492.4
ENST00000368629.1 |
DPYSL4
|
dihydropyrimidinase-like 4 |
| chr7_-_158380465 | 3.75 |
ENST00000389413.3
ENST00000409483.1 |
PTPRN2
|
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
| chr7_+_139208413 | 3.75 |
ENST00000422142.2
|
CLEC2L
|
C-type lectin domain family 2, member L |
| chr19_-_46000251 | 3.75 |
ENST00000590526.1
ENST00000344680.4 ENST00000245923.4 |
RTN2
|
reticulon 2 |
| chr1_+_65720089 | 3.74 |
ENST00000494710.2
|
DNAJC6
|
DnaJ (Hsp40) homolog, subfamily C, member 6 |
| chr6_+_44238203 | 3.73 |
ENST00000451188.2
|
TMEM151B
|
transmembrane protein 151B |
| chr13_-_102068769 | 3.73 |
ENST00000376196.3
|
NALCN
|
sodium leak channel, non-selective |
| chr3_+_85008089 | 3.72 |
ENST00000383699.3
|
CADM2
|
cell adhesion molecule 2 |
| chr8_+_1922024 | 3.71 |
ENST00000320248.3
|
KBTBD11
|
kelch repeat and BTB (POZ) domain containing 11 |
| chr16_+_87425914 | 3.71 |
ENST00000565788.1
|
MAP1LC3B
|
microtubule-associated protein 1 light chain 3 beta |
| chrX_+_2747306 | 3.70 |
ENST00000520904.1
|
GYG2
|
glycogenin 2 |
| chr19_+_30017406 | 3.69 |
ENST00000335523.7
|
VSTM2B
|
V-set and transmembrane domain containing 2B |
| chr7_+_30174574 | 3.68 |
ENST00000409688.1
|
C7orf41
|
maturin, neural progenitor differentiation regulator homolog (Xenopus) |
| chr9_-_101471479 | 3.68 |
ENST00000259455.2
|
GABBR2
|
gamma-aminobutyric acid (GABA) B receptor, 2 |
| chr4_-_6474173 | 3.67 |
ENST00000382599.4
|
PPP2R2C
|
protein phosphatase 2, regulatory subunit B, gamma |
| chr1_-_32229934 | 3.66 |
ENST00000398542.1
|
BAI2
|
brain-specific angiogenesis inhibitor 2 |
| chr3_+_159481791 | 3.66 |
ENST00000460298.1
|
IQCJ-SCHIP1
|
IQCJ-SCHIP1 readthrough |
| chr22_-_44258280 | 3.65 |
ENST00000540422.1
|
SULT4A1
|
sulfotransferase family 4A, member 1 |
| chrX_+_135229731 | 3.63 |
ENST00000420362.1
|
FHL1
|
four and a half LIM domains 1 |
| chr4_+_1003742 | 3.63 |
ENST00000398484.2
|
FGFRL1
|
fibroblast growth factor receptor-like 1 |
| chr11_-_134281812 | 3.62 |
ENST00000392580.1
ENST00000312527.4 |
B3GAT1
|
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
| chr21_+_45285050 | 3.62 |
ENST00000291572.8
|
AGPAT3
|
1-acylglycerol-3-phosphate O-acyltransferase 3 |
| chr3_-_46923653 | 3.61 |
ENST00000431168.1
|
MYL3
|
myosin, light chain 3, alkali; ventricular, skeletal, slow |
| chr18_-_70534745 | 3.60 |
ENST00000583169.1
|
NETO1
|
neuropilin (NRP) and tolloid (TLL)-like 1 |
| chrX_+_21392529 | 3.60 |
ENST00000425654.2
ENST00000543067.1 |
CNKSR2
|
connector enhancer of kinase suppressor of Ras 2 |
| chr19_-_6502341 | 3.59 |
ENST00000598006.1
ENST00000601152.1 |
TUBB4A
|
tubulin, beta 4A class IVa |
| chr19_-_6501778 | 3.57 |
ENST00000596291.1
|
TUBB4A
|
tubulin, beta 4A class IVa |
| chr11_+_1411503 | 3.55 |
ENST00000526678.1
|
BRSK2
|
BR serine/threonine kinase 2 |
| chr1_+_57110972 | 3.54 |
ENST00000371244.4
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit |
| chr19_+_18718214 | 3.54 |
ENST00000600490.1
|
TMEM59L
|
transmembrane protein 59-like |
| chr15_+_27112296 | 3.53 |
ENST00000554038.1
|
GABRA5
|
gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
| chr4_-_154681108 | 3.53 |
ENST00000508248.1
ENST00000274068.4 |
RNF175
|
ring finger protein 175 |
| chr16_+_58497587 | 3.52 |
ENST00000569404.1
ENST00000569539.1 ENST00000564126.1 ENST00000565304.1 ENST00000567667.1 |
NDRG4
|
NDRG family member 4 |
| chr14_+_105190514 | 3.50 |
ENST00000330877.2
|
ADSSL1
|
adenylosuccinate synthase like 1 |
| chr17_+_30593195 | 3.50 |
ENST00000431505.2
ENST00000269051.4 ENST00000538145.1 |
RHBDL3
|
rhomboid, veinlet-like 3 (Drosophila) |
| chr8_-_75233563 | 3.48 |
ENST00000342232.4
|
JPH1
|
junctophilin 1 |
| chr13_+_111767582 | 3.47 |
ENST00000375741.2
ENST00000375739.2 |
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7 |
| chr22_+_26565440 | 3.47 |
ENST00000404234.3
ENST00000529632.2 ENST00000360929.3 ENST00000248933.6 ENST00000343706.4 |
SEZ6L
|
seizure related 6 homolog (mouse)-like |
| chr13_-_114144998 | 3.47 |
ENST00000332592.3
ENST00000439909.2 ENST00000375399.2 |
DCUN1D2
|
DCN1, defective in cullin neddylation 1, domain containing 2 |
| chr16_-_755819 | 3.46 |
ENST00000397621.1
|
FBXL16
|
F-box and leucine-rich repeat protein 16 |
| chr5_+_139175380 | 3.46 |
ENST00000274710.3
|
PSD2
|
pleckstrin and Sec7 domain containing 2 |
| chr12_-_54982300 | 3.45 |
ENST00000547431.1
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
| chr17_-_36762095 | 3.43 |
ENST00000578925.1
ENST00000264659.7 |
SRCIN1
|
SRC kinase signaling inhibitor 1 |
| chr8_-_22014255 | 3.43 |
ENST00000424267.2
|
LGI3
|
leucine-rich repeat LGI family, member 3 |
| chr8_-_80680078 | 3.42 |
ENST00000337919.5
ENST00000354724.3 |
HEY1
|
hes-related family bHLH transcription factor with YRPW motif 1 |
| chr1_+_77747656 | 3.41 |
ENST00000354567.2
|
AK5
|
adenylate kinase 5 |
| chr19_+_35521572 | 3.41 |
ENST00000262631.5
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
| chr22_-_39239987 | 3.40 |
ENST00000333039.2
|
NPTXR
|
neuronal pentraxin receptor |
| chr16_+_58498177 | 3.39 |
ENST00000567454.1
|
NDRG4
|
NDRG family member 4 |
| chr12_-_118498911 | 3.36 |
ENST00000544233.1
|
WSB2
|
WD repeat and SOCS box containing 2 |
| chr6_+_124125286 | 3.36 |
ENST00000368416.1
ENST00000368417.1 ENST00000546092.1 |
NKAIN2
|
Na+/K+ transporting ATPase interacting 2 |
| chr16_+_11762270 | 3.36 |
ENST00000329565.5
|
SNN
|
stannin |
| chr1_-_230561475 | 3.35 |
ENST00000391860.1
|
PGBD5
|
piggyBac transposable element derived 5 |
| chr19_+_13106383 | 3.34 |
ENST00000397661.2
|
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor) |
| chr10_-_134599556 | 3.33 |
ENST00000368592.5
|
NKX6-2
|
NK6 homeobox 2 |
| chr10_-_75634219 | 3.33 |
ENST00000305762.7
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
| chr9_-_140115775 | 3.33 |
ENST00000391553.1
ENST00000392827.1 |
RNF208
|
ring finger protein 208 |
| chr1_+_162039558 | 3.33 |
ENST00000530878.1
ENST00000361897.5 |
NOS1AP
|
nitric oxide synthase 1 (neuronal) adaptor protein |
| chr19_+_54412517 | 3.32 |
ENST00000391767.1
|
CACNG7
|
calcium channel, voltage-dependent, gamma subunit 7 |
| chr11_-_1593150 | 3.32 |
ENST00000397374.3
|
DUSP8
|
dual specificity phosphatase 8 |
| chr6_+_56820152 | 3.31 |
ENST00000370745.1
|
BEND6
|
BEN domain containing 6 |
| chr20_+_58152524 | 3.31 |
ENST00000359926.3
|
PHACTR3
|
phosphatase and actin regulator 3 |
| chr4_-_6202247 | 3.30 |
ENST00000409021.3
ENST00000409371.3 |
JAKMIP1
|
janus kinase and microtubule interacting protein 1 |
| chr9_-_139922631 | 3.29 |
ENST00000341511.6
|
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2 |
| chr12_-_85306562 | 3.29 |
ENST00000551612.1
ENST00000450363.3 ENST00000552192.1 |
SLC6A15
|
solute carrier family 6 (neutral amino acid transporter), member 15 |
| chrX_+_134555863 | 3.28 |
ENST00000417443.2
|
LINC00086
|
long intergenic non-protein coding RNA 86 |
| chr14_-_93582214 | 3.28 |
ENST00000556603.2
ENST00000354313.3 |
ITPK1
|
inositol-tetrakisphosphate 1-kinase |
| chr5_-_14871866 | 3.27 |
ENST00000284268.6
|
ANKH
|
ANKH inorganic pyrophosphate transport regulator |
| chr2_+_236402669 | 3.26 |
ENST00000409457.1
ENST00000336665.5 ENST00000304032.8 |
AGAP1
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
Network of associatons between targets according to the STRING database.
First level regulatory network of SP4_PML
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.5 | 28.0 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 3.3 | 13.1 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 2.4 | 2.4 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 2.4 | 11.9 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 2.1 | 6.3 | GO:1901383 | negative regulation of chorionic trophoblast cell proliferation(GO:1901383) |
| 2.1 | 8.4 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 2.1 | 8.4 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
| 1.8 | 5.5 | GO:0072720 | response to dithiothreitol(GO:0072720) |
| 1.8 | 7.1 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 1.8 | 8.9 | GO:0008050 | female courtship behavior(GO:0008050) |
| 1.7 | 12.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 1.7 | 6.8 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 1.7 | 6.7 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 1.7 | 5.0 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 1.7 | 5.0 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 1.6 | 4.9 | GO:0050894 | determination of affect(GO:0050894) |
| 1.6 | 19.6 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 1.6 | 4.8 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
| 1.6 | 4.7 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
| 1.6 | 7.8 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 1.5 | 4.6 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 1.5 | 7.7 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 1.5 | 7.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.5 | 9.0 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 1.5 | 4.5 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 1.5 | 49.4 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
| 1.5 | 1.5 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
| 1.5 | 4.4 | GO:0040040 | thermosensory behavior(GO:0040040) |
| 1.5 | 4.4 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
| 1.4 | 2.9 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
| 1.4 | 5.7 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 1.4 | 12.7 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 1.4 | 2.8 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 1.4 | 7.0 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 1.4 | 5.5 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
| 1.4 | 2.7 | GO:0099623 | regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
| 1.3 | 8.0 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 1.3 | 1.3 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 1.3 | 13.2 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 1.3 | 3.8 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 1.2 | 2.5 | GO:0072134 | nephrogenic mesenchyme morphogenesis(GO:0072134) |
| 1.2 | 4.9 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
| 1.2 | 2.4 | GO:0021586 | pons maturation(GO:0021586) |
| 1.2 | 3.5 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
| 1.2 | 3.5 | GO:1905033 | positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
| 1.2 | 11.8 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 1.2 | 4.7 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
| 1.2 | 3.5 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
| 1.2 | 12.8 | GO:0046958 | nonassociative learning(GO:0046958) |
| 1.1 | 25.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 1.1 | 12.6 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 1.1 | 3.4 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 1.1 | 7.9 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 1.1 | 7.8 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 1.1 | 13.3 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 1.1 | 6.6 | GO:0001757 | somite specification(GO:0001757) |
| 1.1 | 3.2 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 1.1 | 13.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 1.1 | 2.2 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 1.1 | 3.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 1.1 | 3.2 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 1.1 | 6.4 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 1.1 | 5.3 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 1.0 | 4.2 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 1.0 | 3.1 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 1.0 | 4.2 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 1.0 | 20.7 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 1.0 | 4.1 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 1.0 | 3.1 | GO:0000921 | septin ring assembly(GO:0000921) septin ring organization(GO:0031106) |
| 1.0 | 2.0 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 1.0 | 1.0 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 1.0 | 4.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
| 1.0 | 8.1 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 1.0 | 3.9 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 1.0 | 2.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 1.0 | 2.9 | GO:1904530 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 1.0 | 2.9 | GO:2000374 | regulation of oxygen metabolic process(GO:2000374) |
| 0.9 | 1.9 | GO:2000569 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.9 | 4.7 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.9 | 2.8 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.9 | 2.7 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.9 | 7.2 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
| 0.9 | 7.2 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 0.9 | 2.7 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
| 0.9 | 5.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.9 | 4.4 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.9 | 3.5 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.9 | 4.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.9 | 1.7 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
| 0.9 | 1.7 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.9 | 0.9 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.8 | 3.4 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.8 | 5.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.8 | 5.1 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.8 | 5.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.8 | 3.3 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.8 | 5.0 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.8 | 9.0 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.8 | 7.4 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.8 | 1.6 | GO:0032026 | response to magnesium ion(GO:0032026) |
| 0.8 | 4.9 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.8 | 2.4 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.8 | 0.8 | GO:0003249 | cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
| 0.8 | 2.4 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.8 | 2.4 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.8 | 10.4 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.8 | 1.6 | GO:0090427 | activation of meiosis(GO:0090427) |
| 0.8 | 3.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.8 | 15.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.8 | 17.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.8 | 3.2 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.8 | 7.1 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.8 | 2.3 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.8 | 5.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.8 | 3.1 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.8 | 10.0 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.8 | 10.7 | GO:0071316 | cellular response to nicotine(GO:0071316) |
| 0.8 | 2.3 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 0.8 | 21.9 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.8 | 0.8 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 0.8 | 38.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.8 | 2.3 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.7 | 2.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.7 | 2.9 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.7 | 2.9 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.7 | 0.7 | GO:0070345 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) negative regulation of fat cell proliferation(GO:0070345) |
| 0.7 | 2.2 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.7 | 3.6 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 0.7 | 1.4 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.7 | 2.8 | GO:0032902 | nerve growth factor production(GO:0032902) |
| 0.7 | 11.4 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.7 | 2.1 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.7 | 2.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.7 | 0.7 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.7 | 7.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.7 | 3.5 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.7 | 2.1 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.7 | 3.5 | GO:0030070 | insulin processing(GO:0030070) |
| 0.7 | 2.1 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.7 | 3.5 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.7 | 1.4 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
| 0.7 | 3.5 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.7 | 3.4 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.7 | 26.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.7 | 3.4 | GO:0071874 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.7 | 4.1 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 0.7 | 2.7 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.7 | 11.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.7 | 4.1 | GO:0070541 | response to platinum ion(GO:0070541) |
| 0.7 | 3.4 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.7 | 6.7 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.7 | 1.3 | GO:0006547 | histidine metabolic process(GO:0006547) |
| 0.7 | 2.7 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 0.7 | 4.0 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.7 | 4.6 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.7 | 13.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.7 | 4.6 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.7 | 2.6 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.7 | 0.7 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.7 | 5.2 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.7 | 15.0 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.6 | 0.6 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 0.6 | 1.9 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.6 | 3.2 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.6 | 1.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.6 | 3.2 | GO:1990535 | neuron projection maintenance(GO:1990535) |
| 0.6 | 1.9 | GO:0046041 | ITP metabolic process(GO:0046041) |
| 0.6 | 2.6 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 0.6 | 1.9 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.6 | 12.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.6 | 2.5 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.6 | 8.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.6 | 1.9 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.6 | 5.0 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.6 | 23.4 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.6 | 4.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.6 | 1.8 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 0.6 | 0.6 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.6 | 1.8 | GO:0033058 | directional locomotion(GO:0033058) |
| 0.6 | 1.8 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.6 | 4.9 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.6 | 4.2 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.6 | 0.6 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 0.6 | 1.8 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 0.6 | 1.8 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.6 | 2.4 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.6 | 1.8 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.6 | 2.4 | GO:0089718 | amino acid import across plasma membrane(GO:0089718) |
| 0.6 | 2.4 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.6 | 5.9 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.6 | 1.8 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.6 | 3.5 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.6 | 1.8 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.6 | 0.6 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
| 0.6 | 4.6 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.6 | 2.9 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 0.6 | 3.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.6 | 10.3 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.6 | 0.6 | GO:0099622 | cardiac muscle cell membrane repolarization(GO:0099622) |
| 0.6 | 1.1 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.6 | 2.3 | GO:0042851 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.6 | 2.3 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.6 | 1.7 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.6 | 9.6 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.6 | 3.9 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.6 | 1.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.6 | 14.0 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.6 | 1.7 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.6 | 4.5 | GO:0006083 | acetate metabolic process(GO:0006083) |
| 0.6 | 2.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.6 | 2.8 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.6 | 6.6 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.6 | 2.8 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.5 | 1.6 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.5 | 1.6 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.5 | 1.1 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.5 | 1.6 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 0.5 | 3.2 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.5 | 4.3 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 0.5 | 2.7 | GO:0051204 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) protein insertion into mitochondrial membrane(GO:0051204) |
| 0.5 | 2.7 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.5 | 10.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.5 | 6.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.5 | 1.6 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 0.5 | 3.2 | GO:0035900 | response to isolation stress(GO:0035900) |
| 0.5 | 1.6 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
| 0.5 | 0.5 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 0.5 | 8.3 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
| 0.5 | 1.5 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
| 0.5 | 2.0 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.5 | 6.1 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.5 | 1.0 | GO:0003163 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) |
| 0.5 | 1.0 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 0.5 | 8.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.5 | 0.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.5 | 3.0 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.5 | 2.0 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.5 | 3.0 | GO:0030242 | pexophagy(GO:0030242) |
| 0.5 | 1.5 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.5 | 0.5 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
| 0.5 | 1.5 | GO:0015728 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.5 | 7.4 | GO:0021894 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.5 | 1.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.5 | 0.5 | GO:0032095 | regulation of response to food(GO:0032095) |
| 0.5 | 0.5 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.5 | 1.5 | GO:0015824 | proline transport(GO:0015824) |
| 0.5 | 2.0 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.5 | 0.5 | GO:0036309 | protein localization to M-band(GO:0036309) |
| 0.5 | 2.0 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 0.5 | 2.0 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.5 | 2.9 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.5 | 1.5 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
| 0.5 | 1.0 | GO:0032899 | regulation of neurotrophin production(GO:0032899) |
| 0.5 | 3.8 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
| 0.5 | 10.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.5 | 2.4 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.5 | 6.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.5 | 3.8 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.5 | 1.9 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.5 | 2.9 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.5 | 1.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.5 | 22.3 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.5 | 1.9 | GO:0035668 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.5 | 1.4 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 0.5 | 2.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.5 | 0.5 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
| 0.5 | 5.6 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.5 | 0.5 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.5 | 10.8 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.5 | 2.3 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.5 | 2.3 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.5 | 0.9 | GO:0007032 | endosome organization(GO:0007032) |
| 0.5 | 4.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.5 | 0.5 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.5 | 4.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.5 | 0.5 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.5 | 1.8 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.5 | 1.4 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
| 0.5 | 4.1 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 0.5 | 5.1 | GO:0060732 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.5 | 4.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.5 | 0.5 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.5 | 1.8 | GO:1904799 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.5 | 1.8 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.5 | 5.5 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.5 | 9.5 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.5 | 0.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 0.5 | 1.4 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.5 | 1.4 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 0.5 | 1.8 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.4 | 3.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.4 | 2.7 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.4 | 0.9 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
| 0.4 | 1.3 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.4 | 8.0 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.4 | 9.7 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.4 | 1.8 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.4 | 1.8 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.4 | 5.3 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.4 | 1.3 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.4 | 1.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.4 | 1.7 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.4 | 9.9 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.4 | 0.9 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.4 | 3.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.4 | 2.1 | GO:1901090 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.4 | 1.7 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.4 | 1.3 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 0.4 | 4.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.4 | 0.8 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.4 | 3.8 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.4 | 4.5 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.4 | 10.2 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.4 | 1.2 | GO:1901340 | negative regulation of store-operated calcium channel activity(GO:1901340) |
| 0.4 | 2.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.4 | 19.2 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.4 | 1.2 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.4 | 2.9 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.4 | 3.7 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.4 | 1.6 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 0.4 | 5.7 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.4 | 0.4 | GO:1900125 | regulation of hyaluronan biosynthetic process(GO:1900125) |
| 0.4 | 7.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.4 | 13.0 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.4 | 0.4 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.4 | 3.6 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.4 | 1.2 | GO:0010044 | response to aluminum ion(GO:0010044) |
| 0.4 | 8.0 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.4 | 5.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.4 | 4.4 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.4 | 2.4 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.4 | 4.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.4 | 11.5 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.4 | 3.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.4 | 0.4 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
| 0.4 | 5.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.4 | 2.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.4 | 16.9 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.4 | 7.8 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.4 | 2.0 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.4 | 2.7 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.4 | 1.6 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.4 | 0.4 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
| 0.4 | 1.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.4 | 4.2 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.4 | 5.7 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 0.4 | 2.6 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.4 | 0.4 | GO:0032425 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
| 0.4 | 1.1 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.4 | 2.2 | GO:1902837 | amino acid import into cell(GO:1902837) |
| 0.4 | 6.0 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.4 | 13.0 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.4 | 0.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.4 | 1.1 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.4 | 7.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.4 | 12.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.4 | 11.4 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.4 | 1.8 | GO:2000691 | regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.4 | 0.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.4 | 1.8 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.4 | 1.1 | GO:0060437 | lung growth(GO:0060437) |
| 0.4 | 1.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
| 0.4 | 2.2 | GO:0042391 | regulation of membrane potential(GO:0042391) |
| 0.4 | 0.4 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.4 | 1.1 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) |
| 0.4 | 1.5 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
| 0.4 | 1.5 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.4 | 1.8 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.4 | 3.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.4 | 1.4 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.4 | 1.8 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
| 0.4 | 2.9 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.4 | 0.7 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.4 | 1.4 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.4 | 1.4 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
| 0.4 | 2.5 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.4 | 0.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.4 | 1.8 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
| 0.4 | 1.4 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 0.4 | 1.4 | GO:1904062 | regulation of cation transmembrane transport(GO:1904062) |
| 0.4 | 2.1 | GO:0015853 | adenine transport(GO:0015853) |
| 0.4 | 1.4 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
| 0.4 | 9.2 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.4 | 1.1 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.4 | 1.1 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.4 | 4.9 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.3 | 1.7 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.3 | 1.0 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 0.3 | 2.8 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.3 | 2.1 | GO:0015888 | thiamine transport(GO:0015888) |
| 0.3 | 3.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.3 | 1.0 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.3 | 1.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.3 | 5.2 | GO:1903432 | regulation of TORC1 signaling(GO:1903432) |
| 0.3 | 1.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.3 | 0.7 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
| 0.3 | 1.4 | GO:1903824 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
| 0.3 | 1.7 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.3 | 5.8 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.3 | 1.4 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.3 | 0.7 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
| 0.3 | 1.7 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.3 | 26.5 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
| 0.3 | 1.0 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 0.3 | 7.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.3 | 3.7 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.3 | 1.0 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.3 | 1.7 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.3 | 0.7 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.3 | 1.3 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.3 | 1.7 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.3 | 0.3 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.3 | 0.7 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.3 | 1.3 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.3 | 0.7 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.3 | 1.3 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.3 | 9.6 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.3 | 1.0 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.3 | 0.3 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.3 | 4.3 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
| 0.3 | 1.0 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 0.3 | 2.6 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.3 | 3.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.3 | 4.2 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.3 | 3.9 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.3 | 3.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.3 | 8.7 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.3 | 5.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.3 | 9.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.3 | 2.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.3 | 0.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
| 0.3 | 4.5 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.3 | 7.4 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.3 | 1.0 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.3 | 3.9 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.3 | 0.6 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
| 0.3 | 1.0 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.3 | 0.6 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.3 | 3.8 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
| 0.3 | 4.5 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
| 0.3 | 2.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.3 | 2.9 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.3 | 1.3 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.3 | 5.1 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.3 | 0.9 | GO:1990258 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.3 | 1.3 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.3 | 0.3 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.3 | 7.6 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.3 | 0.6 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.3 | 1.3 | GO:0046545 | development of primary female sexual characteristics(GO:0046545) |
| 0.3 | 1.3 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.3 | 1.6 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.3 | 0.9 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.3 | 4.7 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.3 | 0.3 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
| 0.3 | 1.2 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
| 0.3 | 1.5 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.3 | 0.6 | GO:0009183 | purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 0.3 | 2.2 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.3 | 1.5 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.3 | 1.8 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
| 0.3 | 0.6 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.3 | 2.8 | GO:0006972 | hyperosmotic response(GO:0006972) |
| 0.3 | 0.9 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.3 | 0.9 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
| 0.3 | 2.1 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.3 | 0.6 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.3 | 0.3 | GO:0061740 | protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) |
| 0.3 | 3.0 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.3 | 0.3 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
| 0.3 | 1.8 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.3 | 0.6 | GO:1900166 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
| 0.3 | 1.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.3 | 1.8 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.3 | 0.9 | GO:0070781 | response to biotin(GO:0070781) |
| 0.3 | 0.3 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.3 | 1.8 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.3 | 0.9 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) negative regulation of lamellipodium organization(GO:1902744) |
| 0.3 | 0.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.3 | 3.9 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.3 | 1.2 | GO:0014870 | response to muscle inactivity(GO:0014870) |
| 0.3 | 0.3 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
| 0.3 | 2.7 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.3 | 3.3 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.3 | 14.4 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.3 | 1.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.3 | 3.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.3 | 0.3 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.3 | 0.9 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) negative regulation of integrin biosynthetic process(GO:0045720) |
| 0.3 | 1.2 | GO:0048686 | modulation by virus of host transcription(GO:0019056) regulation of sprouting of injured axon(GO:0048686) positive regulation of sprouting of injured axon(GO:0048687) regulation of axon extension involved in regeneration(GO:0048690) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.3 | 0.9 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.3 | 1.2 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.3 | 0.6 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.3 | 1.5 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.3 | 0.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.3 | 1.2 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.3 | 1.8 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.3 | 3.8 | GO:0060613 | fat pad development(GO:0060613) |
| 0.3 | 2.0 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.3 | 1.7 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.3 | 0.3 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.3 | 0.6 | GO:1901671 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
| 0.3 | 0.3 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
| 0.3 | 22.9 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
| 0.3 | 2.0 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.3 | 0.9 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.3 | 2.6 | GO:0099638 | endosome to plasma membrane protein transport(GO:0099638) |
| 0.3 | 5.2 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.3 | 0.9 | GO:0032328 | alanine transport(GO:0032328) |
| 0.3 | 1.1 | GO:0031456 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.3 | 8.0 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
| 0.3 | 1.1 | GO:0045759 | negative regulation of action potential(GO:0045759) |
| 0.3 | 4.8 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
| 0.3 | 1.7 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.3 | 1.4 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.3 | 1.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.3 | 1.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.3 | 13.3 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.3 | 2.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.3 | 1.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.3 | 0.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.3 | 0.8 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.3 | 8.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.3 | 1.7 | GO:0015692 | lead ion transport(GO:0015692) |
| 0.3 | 7.5 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
| 0.3 | 4.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.3 | 1.1 | GO:0045209 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.3 | 0.3 | GO:2000209 | regulation of anoikis(GO:2000209) negative regulation of anoikis(GO:2000811) |
| 0.3 | 1.7 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.3 | 12.4 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.3 | 1.4 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.3 | 1.9 | GO:0019075 | virus maturation(GO:0019075) |
| 0.3 | 0.8 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.3 | 11.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.3 | 0.3 | GO:0032288 | myelin assembly(GO:0032288) |
| 0.3 | 2.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.3 | 4.1 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
| 0.3 | 1.6 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.3 | 1.1 | GO:0044053 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.3 | 6.2 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.3 | 12.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.3 | 1.1 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.3 | 4.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.3 | 1.1 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
| 0.3 | 1.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.3 | 3.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.3 | 0.5 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.3 | 1.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.3 | 1.9 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.3 | 2.4 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.3 | 0.8 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
| 0.3 | 9.0 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.3 | 2.4 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.3 | 6.9 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.3 | 1.1 | GO:0050993 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.3 | 0.5 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.3 | 3.9 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.3 | 0.8 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.3 | 1.8 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
| 0.3 | 1.8 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.3 | 1.3 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.3 | 1.6 | GO:2000466 | negative regulation of glycogen (starch) synthase activity(GO:2000466) regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.3 | 3.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.3 | 3.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.3 | 1.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.3 | 0.8 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.3 | 1.3 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.3 | 9.5 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.3 | 1.8 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.3 | 0.3 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.3 | 0.8 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.3 | 1.0 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.3 | 1.0 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.3 | 0.8 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.3 | 0.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.3 | 1.8 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.3 | 31.0 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.3 | 0.8 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.3 | 2.8 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.3 | 12.0 | GO:0021762 | substantia nigra development(GO:0021762) |
| 0.3 | 1.0 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.3 | 0.8 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 0.2 | 0.7 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.2 | 0.2 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.2 | 1.2 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
| 0.2 | 0.2 | GO:0021747 | cochlear nucleus development(GO:0021747) |
| 0.2 | 6.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.2 | 0.2 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.2 | 0.5 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.2 | 1.0 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 | 2.0 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.2 | 2.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.2 | 1.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.2 | 1.5 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.2 | 0.7 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.2 | 3.7 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.2 | 0.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.2 | 0.5 | GO:0048259 | regulation of receptor-mediated endocytosis(GO:0048259) |
| 0.2 | 0.2 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) malonyl-CoA metabolic process(GO:2001293) |
| 0.2 | 4.3 | GO:0097286 | iron ion import(GO:0097286) |
| 0.2 | 0.7 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 0.2 | 0.5 | GO:0072019 | proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
| 0.2 | 2.2 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
| 0.2 | 23.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.2 | 2.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
| 0.2 | 1.4 | GO:0018032 | protein amidation(GO:0018032) |
| 0.2 | 1.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.2 | 0.7 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.2 | 2.4 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.2 | 0.9 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.2 | 4.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.2 | 2.4 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.2 | 0.9 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.2 | 1.2 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
| 0.2 | 0.2 | GO:1901626 | regulation of postsynaptic membrane organization(GO:1901626) |
| 0.2 | 2.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.2 | 0.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.2 | 0.2 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.2 | 4.2 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.2 | 1.9 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.2 | 0.7 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.2 | 0.7 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 0.2 | 0.7 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.2 | 0.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.2 | 1.1 | GO:0015862 | uridine transport(GO:0015862) |
| 0.2 | 0.2 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
| 0.2 | 0.5 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
| 0.2 | 0.9 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.2 | 3.4 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.2 | 0.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.2 | 3.9 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.2 | 0.7 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.2 | 0.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.2 | 1.8 | GO:0071205 | protein localization to paranode region of axon(GO:0002175) protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.2 | 1.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.2 | 2.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.2 | 2.7 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
| 0.2 | 1.3 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.2 | 0.2 | GO:0090212 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.2 | 1.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.2 | 0.7 | GO:0021764 | amygdala development(GO:0021764) |
| 0.2 | 2.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.2 | 0.4 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 0.2 | 0.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 0.2 | 0.7 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.2 | 1.8 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.2 | 3.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.2 | 2.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.2 | 0.4 | GO:0008210 | estrogen metabolic process(GO:0008210) |
| 0.2 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.2 | 0.4 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 0.2 | 1.5 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.2 | 0.4 | GO:0060596 | mammary placode formation(GO:0060596) |
| 0.2 | 1.1 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.2 | 2.2 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
| 0.2 | 4.8 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) |
| 0.2 | 0.2 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
| 0.2 | 0.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.2 | 1.7 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.2 | 2.6 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.2 | 0.6 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.2 | 0.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.2 | 1.5 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
| 0.2 | 2.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 0.2 | 4.9 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.2 | 0.6 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
| 0.2 | 5.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.2 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.2 | 0.8 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.2 | 1.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.2 | 0.2 | GO:1904387 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.2 | 8.8 | GO:0097502 | mannosylation(GO:0097502) |
| 0.2 | 4.0 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 0.2 | 1.3 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.2 | 3.4 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.2 | 2.3 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.2 | 0.8 | GO:0070352 | positive regulation of white fat cell proliferation(GO:0070352) |
| 0.2 | 2.9 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.2 | 0.6 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
| 0.2 | 1.3 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
| 0.2 | 3.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.2 | 2.1 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.2 | 0.4 | GO:0019627 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 0.2 | 0.6 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 0.2 | 0.6 | GO:0099627 | neurotransmitter receptor cycle(GO:0099627) |
| 0.2 | 1.9 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.2 | 0.8 | GO:0060066 | glial cell fate determination(GO:0007403) oviduct development(GO:0060066) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
| 0.2 | 0.6 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.2 | 1.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
| 0.2 | 0.2 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
| 0.2 | 1.2 | GO:0051597 | response to methylmercury(GO:0051597) |
| 0.2 | 1.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 | 0.2 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.2 | 0.4 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 0.2 | 2.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.2 | 1.0 | GO:0061760 | antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) |
| 0.2 | 2.4 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 0.2 | 0.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.2 | 4.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.2 | 1.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 | 4.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.2 | 3.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.2 | 0.4 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.2 | 0.6 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.2 | 1.2 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
| 0.2 | 1.6 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.2 | 3.8 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.2 | 0.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.2 | 4.1 | GO:0030516 | regulation of axon extension(GO:0030516) |
| 0.2 | 0.8 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.2 | 1.2 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.2 | 0.2 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
| 0.2 | 0.4 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.2 | 3.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.2 | 7.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.2 | 0.2 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
| 0.2 | 0.6 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.2 | 1.0 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
| 0.2 | 4.1 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.2 | 0.8 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.2 | 0.4 | GO:0015883 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.2 | 0.6 | GO:1902722 | positive regulation of prolactin secretion(GO:1902722) |
| 0.2 | 2.5 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.2 | 2.9 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.2 | 0.6 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.2 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.2 | 0.6 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.2 | 1.5 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
| 0.2 | 0.4 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.2 | 1.3 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.2 | 2.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.2 | 6.4 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
| 0.2 | 1.1 | GO:0021578 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
| 0.2 | 3.0 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.2 | 1.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.2 | 1.5 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.2 | 1.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.2 | 0.7 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.2 | 0.7 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.2 | 7.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.2 | 0.4 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.2 | 0.4 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.2 | 0.6 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.2 | 2.4 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
| 0.2 | 23.8 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.2 | 0.7 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.2 | 0.4 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.2 | 5.9 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.2 | 0.7 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.2 | 16.5 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.2 | 0.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.2 | 0.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.2 | 2.2 | GO:2000322 | regulation of glucocorticoid receptor signaling pathway(GO:2000322) |
| 0.2 | 0.7 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.2 | 1.6 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.2 | 1.8 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.2 | 1.8 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.2 | 0.2 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 0.2 | 0.2 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) serotonin receptor signaling pathway(GO:0007210) |
| 0.2 | 1.6 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.2 | 0.5 | GO:0006528 | asparagine metabolic process(GO:0006528) |
| 0.2 | 0.5 | GO:0070375 | ERK5 cascade(GO:0070375) |
| 0.2 | 2.0 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.2 | 7.1 | GO:0072512 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
| 0.2 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.2 | 3.5 | GO:0008038 | neuron recognition(GO:0008038) |
| 0.2 | 2.3 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.2 | 0.9 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
| 0.2 | 0.5 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.2 | 0.5 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.2 | 1.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.2 | 0.7 | GO:0006813 | potassium ion transport(GO:0006813) |
| 0.2 | 4.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.2 | 0.5 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.2 | 1.4 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.2 | 0.9 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.2 | 2.7 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.2 | 0.2 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.2 | 1.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.2 | 0.3 | GO:1903516 | regulation of single strand break repair(GO:1903516) |
| 0.2 | 3.7 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.2 | 0.8 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.2 | 0.5 | GO:0021554 | optic nerve development(GO:0021554) |
| 0.2 | 1.3 | GO:0042407 | cristae formation(GO:0042407) |
| 0.2 | 0.7 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.2 | 0.3 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
| 0.2 | 2.5 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.2 | 0.7 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 0.2 | 14.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.2 | 1.0 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.2 | 1.3 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.2 | 0.7 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.2 | 0.8 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.2 | 2.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.2 | 1.0 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
| 0.2 | 0.8 | GO:1903613 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.2 | 1.1 | GO:0016129 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.2 | 1.0 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
| 0.2 | 1.3 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.2 | 1.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 0.2 | 1.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.2 | 0.3 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.2 | 0.5 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.2 | 1.0 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
| 0.2 | 0.2 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 0.2 | 0.6 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.2 | 1.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.2 | 4.5 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 0.2 | 0.6 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
| 0.2 | 1.6 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.2 | 0.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.2 | 0.5 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.2 | 4.0 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
| 0.2 | 1.1 | GO:0042262 | DNA protection(GO:0042262) |
| 0.2 | 0.2 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.2 | 0.8 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.2 | 0.3 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.2 | 0.5 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
| 0.2 | 0.6 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.2 | 0.3 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
| 0.2 | 0.5 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.2 | 2.8 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.2 | 1.6 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.2 | 1.3 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.2 | 1.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.2 | 1.2 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.2 | 0.8 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.2 | 0.6 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.2 | 0.6 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
| 0.2 | 0.5 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
| 0.2 | 0.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.2 | 0.9 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.2 | 0.8 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.1 | 0.1 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
| 0.1 | 0.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.1 | 1.5 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
| 0.1 | 0.6 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 | 3.2 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 | 8.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.1 | 0.1 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.1 | 3.1 | GO:0060004 | reflex(GO:0060004) |
| 0.1 | 5.4 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.1 | 0.9 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.1 | 0.4 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) ornithine transport(GO:0015822) |
| 0.1 | 2.9 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.1 | 0.3 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.1 | 0.4 | GO:0046081 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.1 | 1.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 | 0.4 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) |
| 0.1 | 0.4 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 | 0.7 | GO:0003094 | glomerular filtration(GO:0003094) |
| 0.1 | 0.6 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 0.6 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 | 5.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.1 | 0.6 | GO:1990090 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.1 | 5.7 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
| 0.1 | 1.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 | 1.1 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.1 | 0.7 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
| 0.1 | 7.6 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.1 | 1.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.1 | 5.7 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 | 1.4 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
| 0.1 | 4.2 | GO:0046785 | microtubule polymerization(GO:0046785) |
| 0.1 | 0.3 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) transcription factor catabolic process(GO:0036369) |
| 0.1 | 1.0 | GO:0098704 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.1 | 1.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 | 1.2 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
| 0.1 | 0.8 | GO:0048278 | vesicle docking(GO:0048278) |
| 0.1 | 0.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 | 0.7 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
| 0.1 | 0.4 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.1 | 3.7 | GO:0060079 | excitatory postsynaptic potential(GO:0060079) |
| 0.1 | 0.5 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
| 0.1 | 0.7 | GO:0015846 | polyamine transport(GO:0015846) |
| 0.1 | 0.1 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.1 | 2.0 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.1 | 0.4 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.1 | 5.5 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.1 | 5.5 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 | 0.4 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.1 | 0.8 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.1 | 1.2 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
| 0.1 | 1.6 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.1 | 0.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.1 | 4.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.1 | 0.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.1 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.1 | 0.3 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.1 | 0.3 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.1 | 3.1 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.1 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.1 | 0.4 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
| 0.1 | 0.5 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.1 | 0.8 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 0.1 | 1.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.1 | 0.5 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.1 | 0.9 | GO:0032472 | Golgi calcium ion homeostasis(GO:0032468) Golgi calcium ion transport(GO:0032472) |
| 0.1 | 0.8 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
| 0.1 | 2.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
| 0.1 | 0.6 | GO:0061055 | myotome development(GO:0061055) |
| 0.1 | 1.1 | GO:0097576 | vacuole fusion(GO:0097576) |
| 0.1 | 0.3 | GO:1900145 | regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) |
| 0.1 | 2.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 0.8 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.1 | 2.0 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.1 | 0.5 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.1 | 0.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 | 2.2 | GO:0035307 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
| 0.1 | 0.6 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.1 | 0.4 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 0.1 | 0.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.1 | 0.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 | 5.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.1 | 6.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 | 1.0 | GO:0044211 | CTP salvage(GO:0044211) |
| 0.1 | 0.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
| 0.1 | 1.7 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
| 0.1 | 1.6 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.1 | 3.1 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.1 | 0.7 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.1 | 3.4 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.1 | 0.2 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
| 0.1 | 0.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.1 | 0.6 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
| 0.1 | 0.2 | GO:1903333 | regulation of protein folding(GO:1903332) negative regulation of protein folding(GO:1903333) |
| 0.1 | 0.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.1 | 4.0 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.1 | 2.6 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
| 0.1 | 1.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 | 0.2 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 | 2.6 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 0.1 | 0.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.1 | 0.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
| 0.1 | 1.5 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
| 0.1 | 0.6 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.1 | 0.3 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 | 8.0 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
| 0.1 | 0.1 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.1 | 0.1 | GO:0010827 | regulation of glucose transport(GO:0010827) |
| 0.1 | 1.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 | 0.3 | GO:0046832 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.1 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.1 | 0.2 | GO:1900164 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
| 0.1 | 1.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 0.5 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.1 | 0.3 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.1 | 1.5 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 | 0.3 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.1 | 3.9 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 | 0.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.1 | 0.7 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.1 | 0.9 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 | 0.1 | GO:2000584 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.1 | 0.2 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
| 0.1 | 0.3 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.1 | 0.2 | GO:0099637 | neurotransmitter receptor transport(GO:0099637) |
| 0.1 | 0.2 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.1 | 0.3 | GO:0018012 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.1 | 1.8 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.1 | 1.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
| 0.1 | 0.7 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.1 | 0.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.1 | 0.1 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.1 | 0.5 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.1 | 1.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 0.9 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.1 | 0.3 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.1 | 0.7 | GO:0015820 | leucine transport(GO:0015820) |
| 0.1 | 0.2 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
| 0.1 | 3.7 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.1 | 0.2 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
| 0.1 | 0.3 | GO:0006043 | glucosamine catabolic process(GO:0006043) |
| 0.1 | 2.5 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.1 | 1.2 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.1 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.1 | 0.1 | GO:0090647 | modulation of age-related behavioral decline(GO:0090647) |
| 0.1 | 0.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 | 0.5 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 | 20.2 | GO:0007268 | chemical synaptic transmission(GO:0007268) anterograde trans-synaptic signaling(GO:0098916) |
| 0.1 | 0.3 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.1 | 2.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 0.3 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.1 | 0.6 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 | 1.6 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.1 | 0.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 0.1 | 0.3 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.1 | 0.7 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 | 3.8 | GO:0061337 | cardiac conduction(GO:0061337) |
| 0.1 | 1.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 | 1.5 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 0.1 | 0.3 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.1 | 0.2 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
| 0.1 | 1.7 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 | 0.5 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.1 | 0.2 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) positive regulation of histone deacetylase activity(GO:1901727) |
| 0.1 | 8.9 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.1 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 | 1.0 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.1 | 1.0 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
| 0.1 | 0.3 | GO:0072684 | tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.1 | 0.4 | GO:0001964 | startle response(GO:0001964) |
| 0.1 | 0.1 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
| 0.1 | 0.3 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 0.1 | 0.4 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.1 | 0.5 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 0.1 | 0.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
| 0.1 | 0.6 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
| 0.1 | 2.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 | 0.4 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
| 0.1 | 1.4 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.1 | 0.3 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.1 | 0.2 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.1 | 1.5 | GO:1902001 | fatty acid transmembrane transport(GO:1902001) |
| 0.1 | 1.7 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.1 | 1.5 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 0.1 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.1 | 0.5 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.1 | 0.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 0.1 | 1.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.1 | 5.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.1 | 0.6 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.1 | 0.9 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.1 | 1.5 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.1 | 1.1 | GO:0045329 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
| 0.1 | 1.3 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.1 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.1 | 0.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 0.1 | 0.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.1 | 0.4 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 0.1 | 0.1 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 0.1 | 0.1 | GO:0046323 | glucose import(GO:0046323) |
| 0.1 | 0.2 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.1 | 0.4 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.1 | 0.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 | 0.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
| 0.1 | 0.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 | 0.3 | GO:0006273 | lagging strand elongation(GO:0006273) |
| 0.1 | 2.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 1.2 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 0.1 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.1 | 0.1 | GO:0061056 | sclerotome development(GO:0061056) |
| 0.1 | 1.3 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 6.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.1 | 0.2 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.1 | 0.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
| 0.1 | 2.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 | 0.1 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 0.1 | 3.5 | GO:0046324 | regulation of glucose import(GO:0046324) |
| 0.1 | 1.8 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
| 0.1 | 1.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.1 | 0.4 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 0.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.1 | 0.2 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
| 0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.1 | 1.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.1 | 0.3 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.1 | 1.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
| 0.1 | 2.8 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.1 | 1.5 | GO:0048675 | axon extension(GO:0048675) |
| 0.1 | 0.3 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 0.1 | 0.5 | GO:0021781 | glial cell fate commitment(GO:0021781) |
| 0.1 | 2.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 0.3 | GO:0072183 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of nephron tubule epithelial cell differentiation(GO:0072183) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) negative regulation of epithelial cell differentiation involved in kidney development(GO:2000697) |
| 0.1 | 0.3 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.1 | 0.5 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 | 0.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.1 | 0.5 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 | 0.1 | GO:1904882 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.1 | 1.1 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 | 0.3 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.1 | 0.1 | GO:0050893 | sensory processing(GO:0050893) |
| 0.1 | 0.2 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
| 0.1 | 0.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 0.1 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 | 0.5 | GO:0007019 | microtubule depolymerization(GO:0007019) |
| 0.1 | 0.3 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.1 | 0.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.1 | 0.3 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 0.1 | 3.1 | GO:0007602 | phototransduction(GO:0007602) |
| 0.1 | 0.7 | GO:0009629 | response to gravity(GO:0009629) |
| 0.1 | 0.7 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
| 0.1 | 1.9 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
| 0.1 | 1.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 | 0.4 | GO:0033344 | cholesterol efflux(GO:0033344) |
| 0.1 | 0.1 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.1 | 0.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.1 | 0.7 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.1 | 0.6 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
| 0.1 | 1.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
| 0.1 | 1.1 | GO:0031033 | myosin filament organization(GO:0031033) |
| 0.1 | 0.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 | 0.2 | GO:0044062 | regulation of excretion(GO:0044062) |
| 0.1 | 0.8 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.1 | 0.3 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.1 | 0.2 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
| 0.1 | 9.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
| 0.1 | 2.4 | GO:0006836 | neurotransmitter transport(GO:0006836) |
| 0.1 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 0.4 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.1 | 0.3 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.1 | 0.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 | 0.5 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.1 | 11.1 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
| 0.1 | 0.9 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.1 | 0.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 | 0.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 | 1.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 | 0.5 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.1 | 1.3 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.1 | 0.7 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 0.2 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
| 0.1 | 0.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.1 | 0.1 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.1 | 0.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.1 | 0.1 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
| 0.1 | 0.4 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.1 | 0.5 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
| 0.1 | 2.0 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.1 | 0.3 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 | 0.3 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.1 | 0.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.1 | 0.9 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.1 | 0.7 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.1 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 | 0.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.1 | 0.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.1 | 0.3 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.1 | 0.1 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
| 0.1 | 0.2 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.1 | 0.4 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) |
| 0.1 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
| 0.1 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 | 1.0 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
| 0.1 | 0.3 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.1 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.1 | 0.7 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.1 | 0.4 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.1 | 3.5 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.1 | 4.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 0.3 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.1 | 0.7 | GO:0000266 | mitochondrial fission(GO:0000266) |
| 0.1 | 0.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 | 0.7 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.1 | 1.2 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.1 | 0.6 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
| 0.1 | 0.1 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 0.1 | 0.3 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
| 0.1 | 1.2 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
| 0.1 | 1.0 | GO:0046471 | phosphatidylglycerol metabolic process(GO:0046471) |
| 0.1 | 0.7 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 0.1 | 0.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.1 | 1.3 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
| 0.1 | 0.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
| 0.1 | 0.7 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 | 0.9 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.1 | 0.1 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
| 0.1 | 0.1 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 | 0.6 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 | 0.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.1 | 0.2 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 | 0.2 | GO:0006147 | guanine catabolic process(GO:0006147) |
| 0.1 | 0.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 | 0.8 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
| 0.1 | 0.7 | GO:0046677 | response to antibiotic(GO:0046677) |
| 0.1 | 0.1 | GO:0072683 | T cell extravasation(GO:0072683) |
| 0.1 | 0.8 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 | 0.4 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.1 | 0.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.1 | 0.5 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
| 0.1 | 0.4 | GO:0015871 | choline transport(GO:0015871) |
| 0.1 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
| 0.1 | 0.1 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
| 0.1 | 0.3 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.1 | 0.2 | GO:0090009 | primitive streak formation(GO:0090009) |
| 0.1 | 0.4 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.1 | 0.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.1 | 0.2 | GO:0033488 | cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
| 0.1 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.1 | 1.3 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
| 0.1 | 0.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.1 | 0.2 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
| 0.1 | 0.7 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
| 0.1 | 0.1 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.1 | 0.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.1 | 0.7 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.0 | 0.2 | GO:0060048 | cardiac muscle contraction(GO:0060048) |
| 0.0 | 0.1 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
| 0.0 | 0.1 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.0 | 1.0 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.0 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.0 | 0.6 | GO:0006568 | tryptophan metabolic process(GO:0006568) |
| 0.0 | 0.0 | GO:0071871 | response to epinephrine(GO:0071871) |
| 0.0 | 0.1 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
| 0.0 | 0.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.0 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.0 | 0.2 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.0 | 0.5 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 | 0.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.0 | 0.6 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
| 0.0 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.0 | 0.2 | GO:0042428 | serotonin metabolic process(GO:0042428) |
| 0.0 | 1.3 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
| 0.0 | 0.0 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.0 | 0.3 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
| 0.0 | 0.1 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.0 | 0.1 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.0 | 0.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.0 | 0.1 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.0 | 1.0 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
| 0.0 | 0.0 | GO:0060702 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
| 0.0 | 0.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.0 | 0.8 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.0 | 0.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 | 0.1 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
| 0.0 | 0.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.0 | 0.3 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
| 0.0 | 0.1 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.0 | 0.3 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
| 0.0 | 1.0 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.0 | 0.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
| 0.0 | 0.1 | GO:0002215 | defense response to nematode(GO:0002215) |
| 0.0 | 0.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.0 | 0.6 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 | 0.0 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
| 0.0 | 0.2 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.0 | 0.2 | GO:0032621 | interleukin-18 production(GO:0032621) |
| 0.0 | 0.1 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.0 | 0.3 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
| 0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.0 | 4.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
| 0.0 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 | 1.1 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.0 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.0 | 0.1 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.0 | 0.2 | GO:0019640 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.0 | 0.4 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.0 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.0 | 0.1 | GO:0010658 | striated muscle cell apoptotic process(GO:0010658) |
| 0.0 | 0.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 0.0 | 1.1 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.0 | 0.1 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.0 | 0.1 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.0 | 0.1 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.0 | 0.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.0 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 | 0.0 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.0 | 0.4 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.0 | 0.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.0 | 0.3 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
| 0.0 | 0.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
| 0.0 | 0.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
| 0.0 | 0.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.0 | 0.3 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.0 | 0.2 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
| 0.0 | 0.4 | GO:1905037 | autophagosome organization(GO:1905037) |
| 0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 | 0.2 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 0.0 | 0.7 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.0 | 0.1 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.0 | 0.2 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
| 0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 | 0.1 | GO:0060174 | limb bud formation(GO:0060174) |
| 0.0 | 0.1 | GO:1903660 | negative regulation of complement-dependent cytotoxicity(GO:1903660) |
| 0.0 | 0.0 | GO:0071352 | cellular response to interleukin-2(GO:0071352) |
| 0.0 | 0.1 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.0 | 0.4 | GO:0006415 | translational termination(GO:0006415) |
| 0.0 | 0.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.0 | 23.6 | GO:0016567 | protein ubiquitination(GO:0016567) |
| 0.0 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.0 | 0.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.0 | 0.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.0 | 0.7 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.0 | 0.1 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 0.0 | 0.0 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.0 | 0.8 | GO:0000154 | rRNA modification(GO:0000154) |
| 0.0 | 0.1 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.0 | 0.0 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.0 | 0.4 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
| 0.0 | 0.6 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
| 0.0 | 0.1 | GO:0001783 | B cell apoptotic process(GO:0001783) |
| 0.0 | 0.7 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
| 0.0 | 0.0 | GO:0030811 | regulation of nucleotide catabolic process(GO:0030811) |
| 0.0 | 0.0 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.0 | 0.1 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
| 0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
| 0.0 | 0.1 | GO:1904382 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) response to glycoprotein(GO:1904587) |
| 0.0 | 0.1 | GO:1902110 | positive regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902110) mitochondrial outer membrane permeabilization involved in programmed cell death(GO:1902686) |
| 0.0 | 0.2 | GO:0070487 | monocyte aggregation(GO:0070487) |
| 0.0 | 0.2 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.0 | 0.2 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.0 | 1.1 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
| 0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
| 0.0 | 0.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
| 0.0 | 0.2 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.0 | 0.0 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
| 0.0 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.0 | 0.6 | GO:0031529 | ruffle organization(GO:0031529) |
| 0.0 | 0.3 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
| 0.0 | 0.0 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 0.0 | 0.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 | 0.0 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.0 | 0.1 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
| 0.0 | 0.0 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.0 | 0.0 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.0 | 3.9 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
| 0.0 | 0.1 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.0 | 0.1 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
| 0.0 | 0.0 | GO:1902576 | negative regulation of nuclear cell cycle DNA replication(GO:1902576) negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
| 0.0 | 0.0 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.0 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 0.1 | GO:0042255 | ribosome assembly(GO:0042255) |
| 0.0 | 0.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.0 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
| 0.0 | 0.4 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 | 0.0 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
| 0.0 | 0.4 | GO:0015886 | heme transport(GO:0015886) iron coordination entity transport(GO:1901678) |
| 0.0 | 0.2 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.0 | 0.5 | GO:0061512 | protein localization to cilium(GO:0061512) |
| 0.0 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.0 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.0 | 0.1 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.0 | 0.1 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.0 | 0.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.0 | 0.2 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.0 | 0.1 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.0 | 0.0 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.0 | 0.1 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.0 | 0.1 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
| 0.0 | 0.1 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.0 | 0.4 | GO:0051209 | release of sequestered calcium ion into cytosol(GO:0051209) negative regulation of sequestering of calcium ion(GO:0051283) |
| 0.0 | 0.0 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
| 0.0 | 0.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.0 | 0.2 | GO:0006582 | melanin metabolic process(GO:0006582) |
| 0.0 | 0.1 | GO:0030431 | sleep(GO:0030431) |
| 0.0 | 0.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.0 | 0.0 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
| 0.0 | 0.0 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
| 0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 | 0.1 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.0 | 0.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
| 0.0 | 1.3 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
| 0.0 | 0.4 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
| 0.0 | 0.1 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.0 | 0.0 | GO:0015698 | inorganic anion transport(GO:0015698) |
| 0.0 | 0.1 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
| 0.0 | 0.2 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.0 | 0.2 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) |
| 0.0 | 0.2 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.0 | 0.2 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.0 | 0.1 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.0 | 0.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.0 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
| 0.0 | 0.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
| 0.0 | 0.2 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
| 0.0 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.0 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.0 | 0.2 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.0 | 0.1 | GO:0051782 | negative regulation of cell division(GO:0051782) |
| 0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
| 0.0 | 0.6 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
| 0.0 | 0.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.0 | 0.3 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
| 0.0 | 0.0 | GO:0097484 | dendrite extension(GO:0097484) |
| 0.0 | 0.0 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.0 | 0.1 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.0 | 12.0 | GO:0098855 | HCN channel complex(GO:0098855) |
| 2.9 | 23.4 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 2.0 | 16.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 2.0 | 4.0 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
| 1.7 | 15.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 1.7 | 5.0 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
| 1.6 | 22.1 | GO:0033269 | internode region of axon(GO:0033269) |
| 1.5 | 5.8 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 1.3 | 6.7 | GO:0016938 | kinesin I complex(GO:0016938) |
| 1.2 | 4.8 | GO:0072534 | perineuronal net(GO:0072534) |
| 1.2 | 11.8 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 1.2 | 4.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 1.1 | 35.5 | GO:0043194 | axon initial segment(GO:0043194) |
| 1.1 | 5.4 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 1.0 | 3.0 | GO:0005745 | m-AAA complex(GO:0005745) |
| 1.0 | 12.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 1.0 | 8.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 1.0 | 21.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.9 | 13.3 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.9 | 1.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.9 | 6.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.9 | 5.4 | GO:0031673 | H zone(GO:0031673) |
| 0.9 | 3.5 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.9 | 20.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.9 | 4.4 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.8 | 3.4 | GO:0060187 | cell pole(GO:0060187) |
| 0.8 | 32.5 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.8 | 2.5 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
| 0.8 | 6.3 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.8 | 5.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 0.8 | 5.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
| 0.7 | 36.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.7 | 3.0 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 0.7 | 0.7 | GO:0044301 | climbing fiber(GO:0044301) |
| 0.7 | 3.6 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
| 0.7 | 2.1 | GO:1990812 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
| 0.7 | 6.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.7 | 3.5 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.7 | 2.8 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 0.7 | 3.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.7 | 18.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.7 | 4.1 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.7 | 1.4 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.7 | 1.3 | GO:0019034 | viral replication complex(GO:0019034) |
| 0.7 | 46.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.7 | 6.5 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.6 | 1.3 | GO:0045180 | basal cortex(GO:0045180) |
| 0.6 | 6.4 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.6 | 1.9 | GO:0097453 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
| 0.6 | 3.7 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.6 | 5.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.6 | 1.8 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
| 0.6 | 1.2 | GO:0044308 | axonal spine(GO:0044308) |
| 0.6 | 3.0 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.6 | 3.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.6 | 14.2 | GO:0005861 | troponin complex(GO:0005861) |
| 0.6 | 1.8 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.6 | 34.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.6 | 2.3 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.6 | 2.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.6 | 2.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.6 | 11.2 | GO:0031045 | dense core granule(GO:0031045) |
| 0.6 | 3.9 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.5 | 4.3 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.5 | 84.7 | GO:0034705 | potassium channel complex(GO:0034705) |
| 0.5 | 6.4 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.5 | 1.6 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.5 | 1.5 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
| 0.5 | 1.5 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.5 | 60.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.5 | 2.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.5 | 1.5 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
| 0.5 | 10.5 | GO:0016342 | catenin complex(GO:0016342) |
| 0.5 | 8.1 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.5 | 7.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.5 | 5.1 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.5 | 0.9 | GO:0044753 | amphisome(GO:0044753) |
| 0.5 | 2.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.5 | 0.9 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.5 | 14.6 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.5 | 14.9 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.5 | 31.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.4 | 7.6 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.4 | 1.8 | GO:0097635 | extrinsic component of autophagosome membrane(GO:0097635) |
| 0.4 | 8.1 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.4 | 9.3 | GO:0035859 | Seh1-associated complex(GO:0035859) |
| 0.4 | 3.0 | GO:0070470 | plasma membrane respiratory chain(GO:0070470) |
| 0.4 | 159.3 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
| 0.4 | 1.3 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
| 0.4 | 5.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.4 | 3.0 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.4 | 7.9 | GO:0030673 | axolemma(GO:0030673) |
| 0.4 | 1.7 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.4 | 2.9 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.4 | 1.2 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.4 | 2.0 | GO:0051286 | cell tip(GO:0051286) |
| 0.4 | 19.7 | GO:0016528 | sarcoplasm(GO:0016528) |
| 0.4 | 4.8 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.4 | 0.4 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 0.4 | 26.9 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.4 | 5.3 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.4 | 1.5 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 0.4 | 17.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.4 | 2.2 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.4 | 5.2 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.4 | 2.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.4 | 6.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.4 | 13.8 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.4 | 2.5 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.4 | 2.5 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.4 | 18.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.4 | 1.1 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.4 | 2.1 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.4 | 12.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.4 | 4.9 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.4 | 1.8 | GO:0031430 | M band(GO:0031430) |
| 0.3 | 8.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.3 | 2.0 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.3 | 1.3 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.3 | 5.6 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.3 | 1.0 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.3 | 75.3 | GO:0098793 | presynapse(GO:0098793) |
| 0.3 | 1.0 | GO:0043219 | lateral loop(GO:0043219) |
| 0.3 | 1.3 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.3 | 1.0 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.3 | 2.2 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.3 | 5.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.3 | 4.4 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.3 | 5.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.3 | 36.9 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.3 | 1.2 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 0.3 | 0.6 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.3 | 0.3 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.3 | 0.6 | GO:0071437 | invadopodium(GO:0071437) |
| 0.3 | 6.7 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.3 | 0.9 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.3 | 1.1 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.3 | 1.4 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.3 | 4.5 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.3 | 1.7 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.3 | 4.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.3 | 2.7 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.3 | 0.8 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.3 | 11.0 | GO:0005921 | gap junction(GO:0005921) |
| 0.3 | 2.7 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
| 0.3 | 1.3 | GO:0032589 | neuron projection membrane(GO:0032589) |
| 0.3 | 1.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.3 | 2.1 | GO:0030891 | VCB complex(GO:0030891) |
| 0.3 | 1.0 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.3 | 4.4 | GO:0097227 | sperm annulus(GO:0097227) |
| 0.3 | 0.3 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.3 | 1.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.3 | 2.8 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.3 | 5.6 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
| 0.3 | 1.0 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.3 | 1.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.3 | 2.0 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.3 | 2.3 | GO:0031967 | organelle envelope(GO:0031967) envelope(GO:0031975) |
| 0.3 | 2.8 | GO:0043034 | costamere(GO:0043034) |
| 0.2 | 4.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.2 | 3.0 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.2 | 0.7 | GO:0070702 | inner mucus layer(GO:0070702) outer mucus layer(GO:0070703) |
| 0.2 | 27.7 | GO:0005776 | autophagosome(GO:0005776) |
| 0.2 | 2.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.2 | 3.3 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.2 | 2.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.2 | 0.5 | GO:0034657 | GID complex(GO:0034657) |
| 0.2 | 1.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.2 | 4.8 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.2 | 8.2 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
| 0.2 | 45.3 | GO:0031674 | I band(GO:0031674) |
| 0.2 | 19.8 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.2 | 23.7 | GO:0043204 | perikaryon(GO:0043204) |
| 0.2 | 6.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.2 | 0.4 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.2 | 4.0 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.2 | 0.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.2 | 1.7 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.2 | 1.9 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.2 | 1.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.2 | 0.9 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.2 | 7.4 | GO:1990752 | microtubule end(GO:1990752) |
| 0.2 | 8.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.2 | 1.2 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.2 | 0.8 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.2 | 1.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.2 | 0.8 | GO:0097361 | CIA complex(GO:0097361) |
| 0.2 | 3.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.2 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.2 | 0.8 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
| 0.2 | 1.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.2 | 6.2 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.2 | 3.8 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
| 0.2 | 2.2 | GO:0008091 | spectrin(GO:0008091) |
| 0.2 | 13.8 | GO:0030426 | growth cone(GO:0030426) |
| 0.2 | 0.6 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.2 | 1.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.2 | 2.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.2 | 4.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.2 | 1.3 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.2 | 4.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.2 | 0.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.2 | 0.7 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 0.2 | 3.3 | GO:0005875 | microtubule associated complex(GO:0005875) |
| 0.2 | 0.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.2 | 13.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.2 | 6.0 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 0.2 | 6.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.2 | 4.1 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.2 | 0.7 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
| 0.2 | 1.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.2 | 6.1 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
| 0.2 | 0.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.2 | 0.7 | GO:0031213 | RSF complex(GO:0031213) |
| 0.2 | 1.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.2 | 0.8 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
| 0.2 | 1.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.2 | 2.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.2 | 10.0 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.2 | 5.6 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.2 | 1.6 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.2 | 13.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.2 | 4.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.2 | 13.3 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.2 | 0.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.2 | 1.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.2 | 0.9 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.2 | 2.0 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.2 | 0.9 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 0.2 | 1.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.2 | 2.4 | GO:0030904 | retromer complex(GO:0030904) |
| 0.1 | 3.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.1 | 0.6 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.1 | 1.5 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.1 | 33.5 | GO:0030424 | axon(GO:0030424) |
| 0.1 | 2.1 | GO:0032059 | bleb(GO:0032059) |
| 0.1 | 0.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.1 | 4.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 2.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.1 | 1.4 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
| 0.1 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.1 | 39.0 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.1 | 0.6 | GO:0030849 | autosome(GO:0030849) |
| 0.1 | 1.1 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
| 0.1 | 0.9 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.1 | 31.8 | GO:0043025 | neuronal cell body(GO:0043025) |
| 0.1 | 0.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.1 | 1.3 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
| 0.1 | 0.4 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.1 | 2.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.1 | 0.8 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.1 | 1.8 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.1 | 0.5 | GO:0030880 | DNA-directed RNA polymerase complex(GO:0000428) RNA polymerase complex(GO:0030880) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
| 0.1 | 6.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 2.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.1 | 0.5 | GO:1990745 | EARP complex(GO:1990745) |
| 0.1 | 0.4 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
| 0.1 | 1.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.1 | 8.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 2.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 1.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.1 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.1 | 0.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.1 | 1.8 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.1 | 0.6 | GO:0071942 | XPC complex(GO:0071942) |
| 0.1 | 0.4 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.1 | 1.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 0.6 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.1 | 1.3 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
| 0.1 | 0.7 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 0.1 | 77.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 1.1 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 1.8 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 0.1 | 11.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 0.5 | GO:0055087 | Ski complex(GO:0055087) |
| 0.1 | 0.8 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.1 | 1.0 | GO:0033503 | HULC complex(GO:0033503) |
| 0.1 | 0.1 | GO:0070993 | translation preinitiation complex(GO:0070993) |
| 0.1 | 0.2 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 27.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.1 | 0.4 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.1 | 0.8 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.1 | 1.5 | GO:0030133 | transport vesicle(GO:0030133) |
| 0.1 | 0.7 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.1 | 0.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
| 0.1 | 0.6 | GO:0044423 | virion(GO:0019012) virion part(GO:0044423) |
| 0.1 | 19.6 | GO:0019867 | outer membrane(GO:0019867) |
| 0.1 | 145.3 | GO:0005739 | mitochondrion(GO:0005739) |
| 0.1 | 1.1 | GO:0034464 | BBSome(GO:0034464) |
| 0.1 | 1.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.1 | 0.3 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.1 | 1.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 0.2 | GO:0070701 | mucus layer(GO:0070701) |
| 0.1 | 0.7 | GO:0042581 | specific granule(GO:0042581) |
| 0.1 | 1.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
| 0.1 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
| 0.1 | 1.2 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.1 | 0.3 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.1 | 0.3 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.1 | 29.8 | GO:0045202 | synapse(GO:0045202) |
| 0.1 | 1.6 | GO:0030658 | transport vesicle membrane(GO:0030658) |
| 0.1 | 1.7 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 1.4 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 0.8 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.1 | 1.3 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 0.5 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.1 | 0.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.1 | 77.7 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.1 | 0.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.1 | 3.2 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.1 | 0.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.1 | 0.5 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.1 | 2.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 0.3 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.1 | 3.8 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 0.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 1.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.1 | 5.9 | GO:0030425 | dendrite(GO:0030425) |
| 0.1 | 2.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 2.4 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.1 | 0.8 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.1 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.1 | 0.9 | GO:0001939 | female pronucleus(GO:0001939) |
| 0.1 | 0.1 | GO:0043614 | multi-eIF complex(GO:0043614) |
| 0.1 | 6.4 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.1 | 0.1 | GO:0033648 | host intracellular part(GO:0033646) host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) intracellular region of host(GO:0043656) |
| 0.1 | 0.4 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.1 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.1 | 0.5 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.1 | 0.8 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.1 | 0.4 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.1 | 6.5 | GO:0043292 | contractile fiber(GO:0043292) |
| 0.1 | 0.3 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.1 | 3.1 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.1 | 0.4 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.1 | 1.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.1 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.1 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.1 | 0.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.1 | 0.5 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.1 | 0.3 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
| 0.1 | 0.4 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
| 0.1 | 1.5 | GO:0030057 | desmosome(GO:0030057) |
| 0.1 | 0.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.1 | 1.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 26.8 | GO:0005874 | microtubule(GO:0005874) |
| 0.1 | 0.5 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.1 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.1 | 0.5 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.1 | 0.2 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.1 | 0.8 | GO:0099568 | cytoplasmic region(GO:0099568) |
| 0.1 | 1.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.1 | 0.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 0.6 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.1 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.1 | 0.1 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.1 | 1.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 0.5 | GO:0005638 | lamin filament(GO:0005638) |
| 0.1 | 3.8 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.1 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.1 | 0.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.1 | 0.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.1 | 0.6 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.1 | 7.8 | GO:0005769 | early endosome(GO:0005769) |
| 0.1 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.1 | 0.1 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 0.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.1 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.1 | 0.2 | GO:0099513 | polymeric cytoskeletal fiber(GO:0099513) |
| 0.1 | 0.2 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.1 | 1.2 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.1 | 4.1 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.1 | 0.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 0.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.0 | 0.8 | GO:0042641 | actomyosin(GO:0042641) |
| 0.0 | 0.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.0 | 0.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.0 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.0 | 0.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.0 | 0.5 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.0 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.0 | 2.1 | GO:0005814 | centriole(GO:0005814) |
| 0.0 | 0.0 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.0 | 0.0 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.0 | 0.5 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.0 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 0.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.0 | 0.3 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.0 | 6.0 | GO:0010008 | endosome membrane(GO:0010008) |
| 0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.0 | 0.4 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
| 0.0 | 8.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 1.7 | GO:0008305 | integrin complex(GO:0008305) |
| 0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 0.0 | 0.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.0 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.0 | 0.1 | GO:0071159 | NF-kappaB p50/p65 complex(GO:0035525) NF-kappaB complex(GO:0071159) |
| 0.0 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.0 | 0.9 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.0 | 0.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.0 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.0 | 0.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 0.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.0 | 0.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.0 | 4.4 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 0.2 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.0 | 0.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.0 | 11.6 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
| 0.0 | 0.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.0 | 0.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.0 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.0 | 0.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.0 | 0.7 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.0 | 1.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.0 | 0.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.0 | 1.2 | GO:0015030 | Cajal body(GO:0015030) |
| 0.0 | 1.4 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.0 | 0.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 0.2 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.0 | 0.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.0 | 0.6 | GO:0031252 | cell leading edge(GO:0031252) |
| 0.0 | 0.9 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.0 | 1.0 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.0 | 0.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.0 | 0.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.0 | 0.1 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.0 | 0.1 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
| 0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.0 | 0.2 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.0 | 0.1 | GO:0044447 | axoneme part(GO:0044447) |
| 0.0 | 0.1 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 0.0 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.0 | 0.5 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 0.0 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
| 0.0 | 0.1 | GO:0005675 | holo TFIIH complex(GO:0005675) |
| 0.0 | 0.2 | GO:0043235 | receptor complex(GO:0043235) |
| 0.0 | 0.8 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.0 | 0.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.0 | 0.0 | GO:0098791 | Golgi subcompartment(GO:0098791) |
| 0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
| 0.0 | 0.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.0 | 0.3 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.0 | 0.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.0 | 1.0 | GO:0070821 | tertiary granule membrane(GO:0070821) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.5 | 3.5 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 3.5 | 13.9 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 3.0 | 9.0 | GO:0052831 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 2.4 | 12.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 2.3 | 11.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 2.0 | 6.1 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 1.9 | 5.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 1.9 | 16.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 1.9 | 7.5 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
| 1.9 | 9.3 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 1.8 | 5.5 | GO:0038100 | nodal binding(GO:0038100) |
| 1.8 | 7.1 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 1.7 | 5.0 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
| 1.7 | 5.0 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
| 1.7 | 5.0 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
| 1.6 | 4.9 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
| 1.6 | 11.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 1.5 | 6.2 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 1.5 | 4.6 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 1.5 | 4.6 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
| 1.5 | 4.5 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 1.5 | 14.6 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 1.4 | 6.9 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 1.4 | 6.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 1.4 | 4.1 | GO:0086039 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
| 1.3 | 6.6 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 1.3 | 2.6 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
| 1.3 | 11.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 1.3 | 3.9 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 1.3 | 8.8 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 1.2 | 4.9 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 1.2 | 12.2 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 1.2 | 14.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 1.2 | 4.8 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
| 1.2 | 4.8 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 1.2 | 3.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
| 1.1 | 3.4 | GO:0098782 | mechanically-gated potassium channel activity(GO:0098782) |
| 1.1 | 4.5 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 1.1 | 21.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 1.1 | 25.0 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 1.1 | 6.4 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 1.0 | 4.1 | GO:0050421 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
| 1.0 | 6.2 | GO:1903135 | cupric ion binding(GO:1903135) |
| 1.0 | 3.1 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 1.0 | 5.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 1.0 | 18.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 1.0 | 9.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 1.0 | 3.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 1.0 | 4.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 1.0 | 3.9 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 1.0 | 30.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 1.0 | 2.9 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 1.0 | 2.9 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.9 | 3.7 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.9 | 2.7 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
| 0.9 | 0.9 | GO:0016635 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
| 0.9 | 1.8 | GO:0005522 | profilin binding(GO:0005522) |
| 0.9 | 4.4 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 0.8 | 9.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 0.8 | 4.2 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.8 | 5.9 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.8 | 9.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.8 | 4.1 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 0.8 | 2.4 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.8 | 11.3 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.8 | 3.2 | GO:0004325 | ferrochelatase activity(GO:0004325) |
| 0.8 | 7.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.8 | 3.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.7 | 8.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.7 | 2.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.7 | 2.9 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.7 | 5.8 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.7 | 6.5 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.7 | 2.9 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.7 | 3.6 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.7 | 4.3 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.7 | 4.2 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 0.7 | 2.8 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.7 | 16.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.7 | 3.5 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 0.7 | 3.5 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.7 | 3.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.7 | 37.7 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.7 | 2.7 | GO:0004803 | transposase activity(GO:0004803) |
| 0.7 | 6.0 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 0.7 | 6.7 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.7 | 4.0 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.7 | 5.2 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 0.7 | 0.7 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.7 | 1.3 | GO:0097617 | annealing helicase activity(GO:0036310) annealing activity(GO:0097617) |
| 0.6 | 4.5 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.6 | 36.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.6 | 13.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.6 | 1.9 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.6 | 1.9 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.6 | 7.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.6 | 2.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.6 | 9.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.6 | 2.5 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 0.6 | 2.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.6 | 5.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.6 | 8.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.6 | 1.8 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.6 | 38.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.6 | 3.0 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.6 | 2.4 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
| 0.6 | 4.7 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.6 | 23.9 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.6 | 2.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.6 | 2.3 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.6 | 4.0 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.6 | 1.7 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.6 | 4.0 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.6 | 2.3 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.6 | 1.7 | GO:0048244 | phytanoyl-CoA dioxygenase activity(GO:0048244) |
| 0.6 | 1.7 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.6 | 1.1 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.6 | 2.3 | GO:0004057 | arginyltransferase activity(GO:0004057) |
| 0.6 | 3.9 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 0.6 | 2.2 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.6 | 2.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.6 | 6.1 | GO:0046790 | virion binding(GO:0046790) |
| 0.6 | 3.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.6 | 1.7 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.5 | 1.6 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
| 0.5 | 1.6 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
| 0.5 | 17.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.5 | 3.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.5 | 2.2 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.5 | 2.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.5 | 7.9 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.5 | 4.8 | GO:0042835 | BRE binding(GO:0042835) |
| 0.5 | 4.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.5 | 7.4 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.5 | 1.6 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 0.5 | 3.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.5 | 13.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.5 | 6.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.5 | 34.6 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.5 | 1.5 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
| 0.5 | 2.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.5 | 8.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.5 | 9.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.5 | 1.5 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.5 | 4.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.5 | 1.5 | GO:0036440 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
| 0.5 | 1.5 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
| 0.5 | 6.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.5 | 4.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.5 | 1.0 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.5 | 1.5 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 0.5 | 1.5 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.5 | 3.9 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.5 | 8.8 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.5 | 2.0 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.5 | 3.9 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.5 | 4.3 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.5 | 7.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
| 0.5 | 2.4 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.5 | 2.9 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 0.5 | 1.4 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.5 | 1.4 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
| 0.5 | 2.4 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.5 | 1.9 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 0.5 | 9.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.5 | 6.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.5 | 2.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.5 | 1.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.5 | 11.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.5 | 1.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.5 | 4.2 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.5 | 5.0 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.5 | 0.5 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.5 | 0.9 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.4 | 10.8 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.4 | 5.8 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.4 | 6.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.4 | 3.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.4 | 1.8 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 0.4 | 0.4 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
| 0.4 | 17.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.4 | 18.0 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.4 | 1.3 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
| 0.4 | 2.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.4 | 14.3 | GO:0005112 | Notch binding(GO:0005112) |
| 0.4 | 5.6 | GO:0015288 | porin activity(GO:0015288) |
| 0.4 | 1.3 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
| 0.4 | 4.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.4 | 2.6 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.4 | 16.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.4 | 1.7 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
| 0.4 | 3.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.4 | 0.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.4 | 3.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.4 | 9.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.4 | 1.2 | GO:0000406 | double-strand/single-strand DNA junction binding(GO:0000406) dinucleotide repeat insertion binding(GO:0032181) |
| 0.4 | 3.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.4 | 4.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.4 | 3.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.4 | 2.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.4 | 1.2 | GO:0070362 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
| 0.4 | 1.2 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 0.4 | 4.0 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.4 | 8.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.4 | 13.5 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.4 | 1.2 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.4 | 10.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.4 | 2.3 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 0.4 | 7.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.4 | 2.3 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.4 | 1.5 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.4 | 5.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.4 | 1.9 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.4 | 1.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.4 | 2.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.4 | 1.1 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
| 0.4 | 9.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.4 | 2.2 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.4 | 5.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.4 | 13.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.4 | 0.4 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 0.4 | 0.7 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.4 | 1.1 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 0.4 | 1.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.4 | 2.9 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
| 0.4 | 2.2 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.4 | 12.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.4 | 1.1 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
| 0.4 | 3.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.4 | 5.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.4 | 2.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.4 | 4.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.4 | 2.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.4 | 1.1 | GO:0047291 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
| 0.4 | 1.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.4 | 1.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.4 | 1.8 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.4 | 11.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.3 | 8.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.3 | 4.2 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.3 | 3.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.3 | 2.4 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.3 | 3.5 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.3 | 1.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
| 0.3 | 1.0 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.3 | 1.7 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.3 | 0.7 | GO:0070336 | flap-structured DNA binding(GO:0070336) |
| 0.3 | 1.4 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.3 | 0.7 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
| 0.3 | 2.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 0.3 | 2.7 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.3 | 1.0 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
| 0.3 | 1.0 | GO:0031783 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
| 0.3 | 2.0 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.3 | 1.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.3 | 1.3 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.3 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.3 | 25.7 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.3 | 5.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.3 | 1.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.3 | 9.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.3 | 1.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.3 | 1.3 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.3 | 31.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.3 | 1.6 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.3 | 1.9 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
| 0.3 | 1.9 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.3 | 1.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.3 | 4.5 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.3 | 1.0 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.3 | 2.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.3 | 1.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.3 | 0.9 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.3 | 14.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.3 | 1.6 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 0.3 | 2.2 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.3 | 2.5 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.3 | 1.6 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
| 0.3 | 2.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.3 | 8.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.3 | 4.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.3 | 0.6 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.3 | 5.6 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.3 | 10.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.3 | 2.2 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
| 0.3 | 1.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.3 | 1.2 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.3 | 7.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.3 | 0.9 | GO:0046970 | NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
| 0.3 | 0.6 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
| 0.3 | 1.8 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
| 0.3 | 0.6 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
| 0.3 | 1.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.3 | 3.6 | GO:0009374 | biotin binding(GO:0009374) |
| 0.3 | 0.9 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.3 | 0.9 | GO:0061599 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
| 0.3 | 12.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.3 | 1.5 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.3 | 1.7 | GO:0031545 | peptidyl-proline dioxygenase activity(GO:0031543) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.3 | 1.2 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.3 | 1.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.3 | 1.1 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.3 | 5.1 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.3 | 0.6 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.3 | 0.8 | GO:1904854 | proteasome core complex binding(GO:1904854) |
| 0.3 | 1.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.3 | 0.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.3 | 20.8 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.3 | 1.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.3 | 2.7 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.3 | 2.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.3 | 0.8 | GO:0032143 | single thymine insertion binding(GO:0032143) |
| 0.3 | 2.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.3 | 1.9 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 0.3 | 0.8 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.3 | 1.1 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.3 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.3 | 0.8 | GO:0004423 | iduronate-2-sulfatase activity(GO:0004423) |
| 0.3 | 2.4 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.3 | 1.1 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
| 0.3 | 1.1 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
| 0.3 | 1.3 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.3 | 1.3 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
| 0.3 | 0.8 | GO:0004458 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
| 0.3 | 1.0 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
| 0.3 | 108.0 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.3 | 2.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.3 | 3.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.3 | 0.5 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.3 | 5.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.3 | 9.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.3 | 2.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 0.3 | 0.8 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.3 | 1.0 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.3 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.3 | 0.8 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.3 | 2.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.3 | 0.8 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.3 | 0.8 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
| 0.2 | 36.9 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.2 | 1.0 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 0.2 | 1.2 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
| 0.2 | 1.5 | GO:0052846 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.2 | 1.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.2 | 4.7 | GO:0030955 | potassium ion binding(GO:0030955) |
| 0.2 | 2.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.2 | 2.0 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.2 | 7.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.2 | 1.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.2 | 2.2 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.2 | 1.0 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.2 | 7.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.2 | 8.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.2 | 6.9 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.2 | 1.4 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.2 | 2.6 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.2 | 1.4 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 0.2 | 1.9 | GO:0035276 | ethanol binding(GO:0035276) |
| 0.2 | 0.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.2 | 5.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.2 | 2.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.2 | 1.8 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
| 0.2 | 2.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.2 | 0.7 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.2 | 5.5 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.2 | 0.2 | GO:0005272 | sodium channel activity(GO:0005272) |
| 0.2 | 0.7 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.2 | 2.5 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.2 | 6.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.2 | 1.1 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.2 | 2.2 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.2 | 2.0 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.2 | 4.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.2 | 1.8 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.2 | 0.7 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.2 | 3.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.2 | 2.0 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
| 0.2 | 1.9 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.2 | 1.9 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.2 | 2.6 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 0.2 | 0.6 | GO:0031071 | cysteine desulfurase activity(GO:0031071) |
| 0.2 | 3.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.2 | 2.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.2 | 4.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.2 | 1.7 | GO:0048406 | neurotrophin binding(GO:0043121) nerve growth factor binding(GO:0048406) |
| 0.2 | 0.8 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.2 | 0.8 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.2 | 1.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.2 | 9.1 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.2 | 0.8 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.2 | 5.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.2 | 0.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.2 | 0.2 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.2 | 1.5 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.2 | 9.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.2 | 0.8 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.2 | 3.7 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
| 0.2 | 7.3 | GO:0005521 | lamin binding(GO:0005521) |
| 0.2 | 0.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.2 | 1.6 | GO:0035473 | lipase binding(GO:0035473) |
| 0.2 | 4.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.2 | 1.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.2 | 0.4 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
| 0.2 | 7.0 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.2 | 0.6 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
| 0.2 | 15.4 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.2 | 1.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.2 | 2.4 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.2 | 3.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.2 | 1.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.2 | 0.6 | GO:0071253 | connexin binding(GO:0071253) |
| 0.2 | 1.6 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.2 | 0.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
| 0.2 | 1.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.2 | 5.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.2 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.2 | 0.8 | GO:1904493 | Ac-Asp-Glu binding(GO:1904492) tetrahydrofolyl-poly(glutamate) polymer binding(GO:1904493) |
| 0.2 | 1.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.2 | 5.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.2 | 0.4 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
| 0.2 | 0.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.2 | 1.9 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
| 0.2 | 1.3 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.2 | 10.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.2 | 0.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.2 | 1.1 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.2 | 1.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.2 | 0.6 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.2 | 1.9 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.2 | 0.9 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.2 | 1.7 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
| 0.2 | 4.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.2 | 0.7 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.2 | 61.5 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.2 | 2.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.2 | 1.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.2 | 0.5 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.2 | 1.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.2 | 4.5 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.2 | 0.9 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.2 | 4.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.2 | 3.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.2 | 3.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.2 | 2.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.2 | 2.0 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
| 0.2 | 0.2 | GO:0001855 | complement component C4b binding(GO:0001855) |
| 0.2 | 1.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.2 | 1.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.2 | 0.7 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.2 | 3.0 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.2 | 0.9 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.2 | 1.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.2 | 14.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.2 | 2.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.2 | 0.3 | GO:0032551 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
| 0.2 | 0.5 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 0.2 | 0.5 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
| 0.2 | 32.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.2 | 1.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.2 | 2.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.2 | 0.3 | GO:0003909 | DNA ligase activity(GO:0003909) |
| 0.2 | 6.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.2 | 0.5 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 0.2 | 0.7 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 0.2 | 0.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.2 | 0.7 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
| 0.2 | 1.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.2 | 1.3 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.2 | 16.4 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.2 | 8.0 | GO:0016247 | channel regulator activity(GO:0016247) |
| 0.2 | 0.2 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.2 | 0.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
| 0.2 | 1.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.2 | 0.6 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 0.2 | 0.5 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 0.2 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.2 | 2.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.2 | 7.0 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.2 | 2.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.2 | 1.4 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.2 | 0.5 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
| 0.2 | 0.6 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.2 | 2.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.2 | 7.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.2 | 0.3 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
| 0.2 | 0.5 | GO:0015068 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
| 0.2 | 0.2 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.2 | 1.7 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.2 | 2.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.2 | 0.6 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 0.2 | 1.1 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.2 | 0.6 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.2 | 3.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.2 | 1.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 0.2 | 1.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.1 | 1.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.1 | 0.7 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.1 | 5.8 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.1 | 2.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.1 | 3.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.1 | 1.3 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.1 | 1.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.1 | 6.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.1 | 9.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 1.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.1 | 1.3 | GO:0031386 | protein tag(GO:0031386) |
| 0.1 | 0.6 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.1 | 2.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.1 | 0.4 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
| 0.1 | 0.7 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.1 | 0.4 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.1 | 8.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.1 | 1.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 0.1 | 0.4 | GO:0008940 | nitrate reductase activity(GO:0008940) |
| 0.1 | 4.7 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
| 0.1 | 0.1 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
| 0.1 | 0.9 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.1 | 8.5 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.1 | 2.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.1 | 4.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 0.4 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
| 0.1 | 0.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.1 | 0.7 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.1 | 1.0 | GO:0070061 | fructose binding(GO:0070061) |
| 0.1 | 0.3 | GO:0055100 | adiponectin binding(GO:0055100) |
| 0.1 | 0.4 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.1 | 0.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.1 | 1.0 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.1 | 0.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.1 | 0.7 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.1 | 1.2 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.1 | 2.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 1.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.1 | 92.5 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.1 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.1 | 1.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.1 | 1.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.1 | 0.4 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 0.1 | 1.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.1 | 3.2 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.1 | 1.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.1 | 0.5 | GO:1990175 | EH domain binding(GO:1990175) |
| 0.1 | 1.8 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.1 | 0.5 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.1 | 18.4 | GO:0005525 | GTP binding(GO:0005525) |
| 0.1 | 0.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.1 | 0.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.1 | 1.6 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.1 | 18.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.1 | 1.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.1 | 1.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 0.4 | GO:0015491 | cation:cation antiporter activity(GO:0015491) |
| 0.1 | 1.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.1 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.1 | 0.4 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
| 0.1 | 0.4 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
| 0.1 | 1.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.1 | 0.4 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.1 | 0.6 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.1 | 1.2 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.1 | 0.8 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.1 | 1.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.1 | 3.5 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.1 | 0.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.1 | 0.8 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.1 | 2.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.1 | 1.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.1 | 0.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.1 | 1.9 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.1 | 17.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 5.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.1 | 0.3 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.1 | 10.8 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
| 0.1 | 3.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.1 | 1.3 | GO:0043559 | insulin binding(GO:0043559) |
| 0.1 | 0.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.1 | 0.2 | GO:0005503 | all-trans retinal binding(GO:0005503) |
| 0.1 | 2.6 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.1 | 0.3 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
| 0.1 | 0.3 | GO:0043337 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
| 0.1 | 6.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 1.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.1 | 0.3 | GO:0050693 | DBD domain binding(GO:0050692) LBD domain binding(GO:0050693) |
| 0.1 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.1 | 0.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.1 | 0.5 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 0.3 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
| 0.1 | 0.2 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 0.1 | 3.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 0.1 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.1 | 3.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 0.1 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.1 | 0.7 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.1 | 10.9 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.1 | 0.1 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.1 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.1 | 0.9 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.1 | 0.8 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.1 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.1 | 0.8 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.1 | 1.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.1 | 7.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.1 | 3.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.1 | 0.3 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.1 | 0.3 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
| 0.1 | 1.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.1 | 0.4 | GO:0008410 | 3-oxoacid CoA-transferase activity(GO:0008260) CoA-transferase activity(GO:0008410) |
| 0.1 | 0.1 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
| 0.1 | 0.9 | GO:0016595 | glutamate binding(GO:0016595) |
| 0.1 | 0.1 | GO:0000248 | C-5 sterol desaturase activity(GO:0000248) sterol desaturase activity(GO:0070704) |
| 0.1 | 0.7 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.1 | 1.0 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.1 | 0.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.1 | 0.4 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.1 | 0.7 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.1 | 2.2 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.1 | 0.5 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.1 | 0.6 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.1 | 1.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 0.2 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 0.1 | 0.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.1 | 3.1 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.1 | 0.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.1 | 1.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.1 | 0.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.1 | 0.4 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.1 | 0.3 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.1 | 0.2 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.1 | 0.7 | GO:0030249 | cyclase activator activity(GO:0010853) guanylate cyclase regulator activity(GO:0030249) guanylate cyclase activator activity(GO:0030250) |
| 0.1 | 2.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 0.2 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 0.1 | 8.8 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.1 | 0.4 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.1 | 12.4 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.1 | 1.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.1 | 0.3 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.1 | 0.3 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 0.1 | 0.3 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
| 0.1 | 0.3 | GO:0030626 | U12 snRNA binding(GO:0030626) |
| 0.1 | 2.3 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 0.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.1 | 0.5 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.1 | 0.6 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 0.1 | 1.8 | GO:0043531 | ADP binding(GO:0043531) |
| 0.1 | 4.5 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.1 | 0.2 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
| 0.1 | 1.0 | GO:0071949 | FAD binding(GO:0071949) |
| 0.1 | 0.3 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.1 | 0.2 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.1 | 1.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.1 | 0.3 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.1 | 1.3 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
| 0.1 | 0.9 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.1 | 0.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.1 | 0.5 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.1 | 0.3 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.1 | 0.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
| 0.1 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
| 0.1 | 0.2 | GO:0016499 | orexin receptor activity(GO:0016499) |
| 0.1 | 1.0 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 0.8 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 0.1 | 2.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 1.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.1 | 0.2 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 0.6 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.1 | 0.5 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.1 | 3.9 | GO:0015631 | tubulin binding(GO:0015631) |
| 0.1 | 0.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
| 0.1 | 0.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.1 | 0.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.1 | 0.7 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.1 | 0.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.1 | 1.8 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.1 | 0.3 | GO:0016885 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
| 0.1 | 0.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
| 0.1 | 0.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.1 | 0.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.1 | 2.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.1 | 0.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 1.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.1 | 35.4 | GO:0003779 | actin binding(GO:0003779) |
| 0.1 | 0.2 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.1 | 0.5 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.1 | 0.5 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.1 | 0.5 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.1 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
| 0.1 | 0.3 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.1 | 1.3 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.1 | 0.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.1 | 0.1 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
| 0.1 | 0.8 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.1 | 0.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.1 | 2.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 0.1 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
| 0.1 | 2.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.1 | 0.2 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 0.1 | 0.5 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.1 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.1 | 0.5 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
| 0.1 | 1.2 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.1 | 1.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.1 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.1 | 0.7 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.1 | 0.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.1 | 0.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.1 | 0.1 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
| 0.1 | 0.2 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 0.1 | 0.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.1 | 0.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.1 | 1.5 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.1 | 2.2 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.1 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.1 | 0.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.1 | 0.3 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.1 | 0.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.1 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.1 | 0.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 19.0 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.1 | 0.2 | GO:0008398 | sterol 14-demethylase activity(GO:0008398) |
| 0.1 | 0.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.1 | 2.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 1.4 | GO:1901981 | phosphatidylinositol phosphate binding(GO:1901981) |
| 0.1 | 2.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.1 | 0.6 | GO:0004691 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 0.3 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.0 | 1.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.0 | 0.1 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.0 | 0.0 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
| 0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.0 | 0.2 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.0 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.0 | 0.1 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
| 0.0 | 2.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.0 | 0.2 | GO:0005019 | platelet-derived growth factor beta-receptor activity(GO:0005019) |
| 0.0 | 0.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.0 | 0.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.0 | 1.8 | GO:0000287 | magnesium ion binding(GO:0000287) |
| 0.0 | 1.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.0 | 0.2 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.0 | 0.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.0 | 1.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.0 | 0.1 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
| 0.0 | 0.2 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.0 | 0.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.0 | 0.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
| 0.0 | 0.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.0 | 0.6 | GO:0019841 | retinol binding(GO:0019841) |
| 0.0 | 0.1 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.0 | 0.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.0 | 0.6 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
| 0.0 | 0.2 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 0.0 | 0.4 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.0 | 0.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.0 | 0.0 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.0 | 0.9 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.0 | 0.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.0 | 0.5 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.0 | 0.6 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.0 | 0.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.0 | 0.1 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.0 | 1.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.0 | 2.0 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.0 | 0.1 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.0 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.0 | 1.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.0 | 0.1 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.0 | 0.0 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
| 0.0 | 1.4 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.0 | 0.1 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.0 | 0.3 | GO:0052723 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 0.0 | 0.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.0 | 0.5 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.0 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.0 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.0 | 1.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.0 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.0 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.0 | 0.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.0 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.0 | 0.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.0 | 0.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.0 | 0.2 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.0 | 0.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.0 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
| 0.0 | 0.1 | GO:0047536 | 2-aminoadipate transaminase activity(GO:0047536) |
| 0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.0 | 0.1 | GO:0036317 | tyrosyl-RNA phosphodiesterase activity(GO:0036317) 5'-tyrosyl-DNA phosphodiesterase activity(GO:0070260) |
| 0.0 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.0 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.0 | 0.3 | GO:0030145 | manganese ion binding(GO:0030145) |
| 0.0 | 0.1 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.0 | 0.1 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.0 | 0.3 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.0 | 0.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.0 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.0 | 0.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.0 | 0.7 | GO:0030295 | protein kinase activator activity(GO:0030295) |
| 0.0 | 0.1 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.0 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.0 | 0.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.0 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.0 | 0.1 | GO:0019209 | kinase activator activity(GO:0019209) |
| 0.0 | 0.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.0 | 0.5 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.0 | 0.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.0 | 1.4 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.0 | 0.1 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.0 | 0.0 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
| 0.0 | 0.1 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.0 | 0.1 | GO:0045182 | translation regulator activity(GO:0045182) |
| 0.0 | 0.2 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.0 | 0.0 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.0 | 0.0 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.0 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.0 | 1.5 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.0 | 0.0 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.0 | 0.1 | GO:0070990 | snRNP binding(GO:0070990) |
| 0.0 | 0.5 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.0 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.0 | 0.5 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.0 | 0.0 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 0.0 | 0.4 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) |
| 0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.0 | 0.2 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.0 | 0.0 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.0 | 0.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 33.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.6 | 1.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.5 | 1.0 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.5 | 3.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.4 | 12.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.4 | 10.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.4 | 29.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.4 | 46.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.4 | 0.8 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.4 | 20.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.3 | 16.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.3 | 12.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.3 | 12.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.3 | 23.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.3 | 6.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.3 | 19.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.3 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.3 | 21.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.3 | 6.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.2 | 11.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.2 | 7.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.2 | 6.8 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.2 | 4.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.2 | 5.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.2 | 4.0 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.2 | 4.7 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.2 | 3.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.2 | 7.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.2 | 6.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.2 | 0.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.2 | 2.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.2 | 8.9 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.2 | 4.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.1 | 2.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.1 | 1.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.1 | 3.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 14.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.1 | 7.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.1 | 1.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 11.4 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 9.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 1.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 1.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.1 | 6.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.1 | 5.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.1 | 2.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.1 | 6.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.1 | 9.1 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.1 | 4.8 | PID FOXO PATHWAY | FoxO family signaling |
| 0.1 | 2.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 1.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.1 | 2.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.1 | 2.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 3.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.1 | 4.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 0.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 1.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.1 | 0.9 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.1 | 0.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.1 | 4.6 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.1 | 0.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.1 | 3.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.1 | 3.2 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 0.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.1 | 1.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.1 | 1.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.1 | 5.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.1 | 1.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.1 | 1.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 6.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 0.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.1 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 0.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.1 | 1.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.1 | 5.4 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 6.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 1.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 4.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 1.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.1 | 1.4 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.1 | 2.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.0 | 1.6 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.0 | 3.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.0 | 0.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.0 | 0.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.0 | 1.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 0.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 0.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.0 | 3.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 0.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.0 | 0.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.0 | 0.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.0 | 1.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.0 | 0.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.0 | 0.2 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 43.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 1.2 | 60.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 1.0 | 23.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.9 | 0.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.9 | 14.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 0.8 | 15.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.8 | 28.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.7 | 42.8 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.6 | 1.3 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 0.6 | 24.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.6 | 2.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.6 | 12.5 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
| 0.5 | 12.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.5 | 19.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.5 | 35.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.5 | 9.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.5 | 33.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.5 | 50.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.5 | 32.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.5 | 17.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.4 | 4.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.4 | 2.7 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.4 | 12.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.4 | 12.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.4 | 9.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.4 | 15.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.4 | 4.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.4 | 91.1 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
| 0.4 | 12.0 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
| 0.4 | 1.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.4 | 12.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.4 | 14.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.4 | 1.4 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
| 0.3 | 5.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.3 | 18.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.3 | 6.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.3 | 12.8 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
| 0.3 | 2.6 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
| 0.3 | 4.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.3 | 6.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.3 | 6.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.3 | 6.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.3 | 6.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.3 | 19.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.3 | 6.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.3 | 5.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.3 | 13.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.3 | 6.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.3 | 1.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.2 | 7.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.2 | 7.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.2 | 5.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.2 | 1.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.2 | 6.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.2 | 13.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.2 | 3.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.2 | 2.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.2 | 18.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.2 | 0.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.2 | 2.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.2 | 7.8 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.2 | 3.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.2 | 0.6 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
| 0.2 | 2.4 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
| 0.2 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.2 | 3.8 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.2 | 5.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.2 | 24.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.2 | 3.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.2 | 1.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.2 | 7.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.2 | 28.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.2 | 1.4 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
| 0.2 | 2.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.2 | 14.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.2 | 3.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.2 | 1.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.2 | 0.7 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.2 | 8.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.2 | 3.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 8.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.2 | 3.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.2 | 4.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.2 | 2.9 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.2 | 15.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.2 | 2.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.2 | 4.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.2 | 4.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.2 | 5.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.2 | 2.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.1 | 6.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 1.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.1 | 2.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.1 | 2.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.1 | 1.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.1 | 1.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 0.3 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
| 0.1 | 4.5 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.1 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.1 | 5.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 7.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 2.8 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.1 | 1.4 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.1 | 3.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.1 | 1.7 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.1 | 3.7 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
| 0.1 | 6.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 2.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.1 | 3.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.1 | 37.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.1 | 11.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.1 | 0.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 2.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 1.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.1 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.1 | 2.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.1 | 2.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.1 | 2.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 1.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 1.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.1 | 15.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 3.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.1 | 1.6 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.1 | 12.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.1 | 3.2 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.1 | 1.9 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
| 0.1 | 1.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.1 | 1.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 1.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.1 | 3.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 2.7 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
| 0.1 | 1.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 1.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.1 | 2.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 1.6 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.1 | 5.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.1 | 0.8 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
| 0.1 | 0.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.1 | 0.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.1 | 1.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.1 | 5.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
| 0.0 | 0.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.0 | 1.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.0 | 0.6 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.0 | 1.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.0 | 1.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.0 | 1.1 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.0 | 0.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.0 | 4.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.0 | 0.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 0.0 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
| 0.0 | 1.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.0 | 1.6 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
| 0.0 | 0.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.0 | 0.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.0 | 0.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.0 | 0.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.0 | 0.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 0.5 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.0 | 1.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 0.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.0 | 0.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.0 | 0.3 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
| 0.0 | 0.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.0 | 0.2 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
| 0.0 | 2.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |